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ABSTRACT OF THE DISSERTATION
SYNTHESIS OF AZULENYLSILANE NITRONES AS DIAGNOSTIC TOOLS FOR
SUPEROXIDE DETECTION
by
Relina Tamrakar
Florida International University, 2011
Miami, Florida
Professor David Becker, Major Professor
The superoxide radical is considered to play important roles in physiological
processes as well as in the genesis of diverse cytotoxic conditions such as cancer, various
cardiovascular disorders and neurodegenerative diseases such as amyotrophic lateral
sclerosis (ALS), Parkinson’s disease (PD) and Alzheimer’s disease (AD). The detection
and quantification of superoxide within cells is of critical importance to understand
biological roles of superoxide and to develop preventive strategies against free radicalmediated diseases. Cyclic nitrone spin traps such as DMPO, EMPO, DEPMPO, BMPO
and their derivatives have been widely used in conjunction with ESR spectroscopy to
detect cellular superoxide with some success. However, the formation of unstable
superoxide adducts from the reaction of cyclic nitrones with superoxide is a stumbling
block in detecting superoxide by using electron spin resonance (ESR). A
chemiluminescent probe, lucigenin, and fluorogenic probes, hydroethidium and MitoSox,
are the other frequently used methods in detecting superoxide. However, luceginen
undergoes redox-cycling producing superoxide by itself, and hydroethidium and MitoSox
react with other oxidants apart from superoxide forming red fluorescent products
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contributing to artefacts in these assays. Hence, both methods were deemed to be
inappropriate for superoxide detection.
In this study, an effective approach, a selective mechanism-based colorimetric
detection of superoxide anion has been developed by using silylated azulenyl nitrones
spin traps. Since a nitrone moiety and an adjacent silyl group react readily with radicals
and oxygen anions respectively, such nitrones can trap superoxide efficiently because
superoxide is both a radical and an oxygen anion. Moreover, the synthesized nitrone is
designed to be triggered solely by superoxide and not by other commonly observed
oxygen radicals such as hydroxyl radical, alkoxyl radicals and peroxyl radical. In vitro
studies have shown that these synthesized silylated azylenyl nitrones and the
mitochondrial-targeted guanylhydrazone analog can trap superoxide efficiently yielding
UV-vis identifiable and even potentially fluorescence-detectable orange products.
Therefore, the chromotropic detection of superoxide using these nitrones can be a
promising method in contrast to other available methods.
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[1] INTRODUCTION
Increasing evidence of involvement of superoxide radical anion (O2•-) as a
mediator of various pathological diseases,1-3 and its importance in physiological
processes led to the development of methods for detecting superoxide radical anion over
the past decades. By far, the most commonly used probes include cyclic nitrones,
hydroethidine, nitro blue tetrazolium, and other chemiluminescent and fluorescent
species have received a criticism for various reasons.4-7 To overcome the existing
problem associated with these probes, an effective approach, a selective, mechanismbased colorimetric detection of superoxide anion has been developed by using a novel
silylated azulenyl nitrone spin trap. The synthesized nitrones were found to trap
superoxide anion, and hence, can be the potential biomarkers for superoxide production.
The synthesized spin traps could offer a highly convenient method compared to other
available colorimetric detection methods. My research describes the design, synthesis,
chemical properties, testing and potential use of new silylated azulenyl nitrone
compounds.
[1.1] Historical Background
Over the past decades, it has been established that radicals are ubiquitous in
nature, and have a large impact on our lives. They are present in our bodies, produced in
the atmosphere and during some important chemical reactions essential to life. Although,
more than a century ago Gomberg had established the existence of a relatively stable
carbon-centered free radical, the triphenyl methyl radical,8 it was not until five decades
later that considerable importance of free radicals in chemistry and biology was
recognized. In 1954, Gershman reported that oxygen poisoning damage is related to the
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formation of free radicals during the reduction of oxygen.9 Soon after her publication, in
the same year, free radicals were first detected in lyophilised biological materials by
Commoner et al. using ESR.10 With this breakthrough discovery, investigations into the
role of free radicals in biological systems were spurred. In 1956, Harman proposed his
free radical theory of aging,11 in which it was suspected that aging and degenerative
diseases were associated with the activity of free radicals. Gradually, in 1969, with the
discovery of an enzyme called superoxide dismutase (SOD), McCord and Fridovich
solidified the importance of free radicals in the life sciences.12 They demonstrated that
in biological systems, widely distributed superoxide dismutase catalyzes the dismutation
of superoxide free radical anion (O2•-) to yield oxygen and hydrogen peroxide and might
play a vital role in protecting the organism against the detrimental effects of the
superoxide radical anion. Free radicals are considered to be reactive intermediates and
involved in many biologically destructive processes. Free radicals are able to damage
macromolecules such as cellular lipids, proteins, carbohydrates and nucleic acids by
reacting with them and disabling their normal functions. Once viewed as exclusively
harmful species to organisms, beneficial roles of free radicals in physiological processes
were first recognized in the 1970s. Work conducted by Millar and Murad indicated that
the formation of hydroxyl radical (HO•) from superoxide ion and hydrogen peroxide
actually stimulates activation of guanylate cyclase which catalyzed the formation of the
“second messenger” 3',5'-cyclic guanosine monophosphate (cGMP) from guanosine
triphosphate GTP.13 During the oxidative burst of phagocytic cells, free radicals are
sequentially generated to attack invasive microorganisms.14,15 It has also been known that
reactive oxygen species play important roles in the regulation of cardiac and vascular cell
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functioning.16 Moreover, free radicals increase the production of the T-cell growth factor
interleukin-2, an immunologically important T-cell protein.17
Although the existence of free radicals is essential in maintaining cell viability in
living organisms, their accidental damage to cells is inevitable. The overproduction of
free radicals results in the formation of highly oxidizing species resulting in cellular
dysfunction.18 Ultimately, the oxidative stress on cells is thought to make a significant
contribution to a variety of diseases such as ischemia-reperfusion injury,19 cancer,20,21
acute stroke,22 Alzheimer’s disease,23,24 cardiovascular disease,25 neurodegenerative
disease,26 Down’s syndrome, and diabetes.27-29 More importantly, it seems that cells
maintain a careful balance between beneficial and deleterious effects of free radicals, and
this mechanism is obviously a critical aspect of our life. It becomes imperative to have
“real-time” monitoring and measurement of these free radicals within cell for further
investigation of their physiological and pathological roles that may ultimately lead to the
development of new strategies for treatment.
[1.2] Free Radicals
A free radical is defined as an atomic, molecular or ionic species which possesses
one or more unpaired electrons in its outermost shell.30 The presence of an unpaired
electron sharply enhances their reactivity with other atoms or molecules especially in
hydrogen atom abstraction, in the addition of double bonds in organic compounds and in
a variety of other reactions to achieve a stable configuration. Free radicals can have
positive, negative or neutral charge. In the biosciences, two types of radicals are
commonly encountered, the carbon-centered radical (•R) in which the unpaired electron
resides on the carbon atom, and the oxygen-centered radical (•O) in which the unpaired

3

electron resides on the oxygen atom. Oxygen-centered radicals are among a group of
molecules known as reactive oxygen species (ROS). Of the two aforementioned radical
types, oxygen-centered radicals such as superoxide anion radical, hydroxyl radical, and
peroxyl radicals are believed by many to be the major cause of vascular diseases and
pathological conditions in biological systems.
[1.3] Superoxide radical anion
Among the reactive oxygen species, superoxide radical anion (O2•-) is the most
important species because it is a progenitor of other reactive oxygen species in biological
systems. A ground state oxygen molecule dissolved in aprotic solvents undergoes
electrochemical reduction by gaining one electron to form superoxide radical anion based
on the work of Sawyer and his co-worker31,32 according to the following reaction.
O2 +

e-

O2•-

(1)

With one electron in its outermost shell, superoxide radical anion is paramagnetic. The
bond distance between O-O is 1.33oA. In aqueous media, superoxide radical anion is
always in equilibruim with the hydroperoxyl radical as shown in equation 2.33
H2O + O2•-

HOO• + OH

(2)

The electronic structure of superoxide anion contains three electrons in two
separate antibonding orbitals (π*, 2p), one with paired and another with unpaired
electrons.34 Hence, O2•- is both a radical and anion species. When dissolved in organic
solvents, it is very reactive.35 In water, superoxide anion has been demonstrated to be a
strong proton acceptor with at least four molecules of water through hydrogen bonding.36
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It is unstable and disproportionates in water and readily forms oxygen and hydrogen
peroxide. Superoxide radical anion can act as an one electron acceptor as well as one
electron donor depending on the nature of substrate with which it is reacting.37 Therefore,
it becomes involved in both oxidation and reduction reactions. If a substrate has strong
electron affinity, it undergoes superoxide-mediated one electron reduction. However,
with an electron-deficient substrate, superoxide can act as a nucleophile or undergo oneelectron transfer to give molecular oxygen.
[1.4] Formation of superoxide radical in biological systems
In biological systems, the superoxide radical anion, O2•-, is not a very reactive
damaging agent but plays a critical role in the formation of other harmful reactive oxygen
species (ROS) that have been implicated in the genesis of various pathological
conditions. These reactive oxygen species include, reactive radicals such as hydroxyl
radicals (HO•), hydroperoxyl radicals (HOO•), peroxyl radicals (ROO•), alkoxyl radicals
(RO•), the carbonate radical anion (CO3•-) and non-radicals such as hydrogen peroxide
(H2O2), alkyl hydroperoxides (ROOH), hypochlorous acid (HOCl), singlet oxygen (1O2)
and peroxynitrite anion (ONOO-). Secondary reactive oxygen species are also produced
from singlet oxygen, ionizing radiation38 and peroxynitrite anion, but with less
frequency.39 Superoxide radical anion productions can be both enzymatically and nonenzymatically mediated.
[1.4.1] Electron transport chain as a source of superoxide radical
Molecular oxygen is an essential component for living organisms to survive, and
is widely distributed. Aerobic cells utilize oxygen to oxidize organic substrates for energy
generation. During cellular respiration, oxygen, by accepting electrons, is consumed
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along with metabolic substrates that undergo oxidation to produce ATP, water and carbon
dioxide. The cellular respiration takes place in mitochondria via a pathway known as the
electron transport chain (ETC). The ETC consists of several electron acceptor enzyme
complexes in the inner membrane of the mitochondrion.40 In this mechanism, electrons
are passed from one molecule to another producing a proton gradient across the
mitochondrial membrane each time until electrons are passed to oxygen to produce water
and energy (ATP). The electrons from oxidation reduce oxygen to water in myocardial
cells via two pathways.41 The mitochondrial electron transport chain reduces ~95 % of
oxygen to water by the tetravalent pathway.41 The reduction of oxygen requires four
electrons to each oxygen molecule as shown in the reaction 3 where Eφ is the standard
reduction potential.42
O2 + 4H+ + 4e-

2H2O

Eφ=+0.82V

(3)

It is believed that under normal conditions, molecular oxygen metabolism
proceeds via a series of four sequential univalent reduction reactions (four-one electron
addition reactions) to form two molecules of water that also results in the formation of
two free radicals and one hydrogen peroxide molecule as shown in the overall process.43
The pKa of the equilibrium between superoxide anion and its conjugated base H2O• is 4.8
implying that O2•- is the dominant species at physiological pH and mediates the further
steps.
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O2 + e-

O2•- (+ H+

O2•- + e-

O2--(+ 2H

H2O2 + e- + H+
HO• + e- + H+

Eo= -0.33V

H2O•)
+

H2O2 + O2)

HO• + H2O
H2O

E’= +0.28V (4)

Eo= +0.87V

E’= +0.63V (5)

Eo= +0.38V

E’= +0.73V (6)

Eo= +2.33V

E’= +1.56V (7)

The thermodynamic parameters of this process are reported by Fee and
Valentine44 where Eo is the standard cell potential and E’ is the potential at the
physiological conditions (pH 7, 25oC) of the specific intermediate. To reduce oxygen by
accepting one electron to form superoxide anion is thermodynamically very unfavorable
compared to the other reductions. However, once the first step takes place, the remaining
steps will occur spontaneously giving minimal chance for the occurrence of only partial
univalent reduction of oxygen. The entire process takes place in the enzyme active site
where oxygen is incorporated into protein and bound to it so that it cannot leave until it is
converted into water. However, it is estimated that ~ 2 %

45

to ~5 % (in the

myocardium)41 of the electron flow through the electron transport chain, is subjected to
one univalent reduction of molecular oxygen generating superoxide radical anion. The
partial univalent pathway occurs when electrons are leaked from the electron transport
chain during the terminal enzyme complex reduction in mitochondria. Molecular tripletstate oxygen then accepts these leaked electrons to form superoxide radical anion46 and
once in its anionic form, it can easily cross the inner mitochondrial membrane.
[1.4.2] Enzymatic source of superoxide radical
In phagocytes, the superoxide radical anion is also produced by the leukocyte
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enzyme NADPH oxidase.47 Phagocytic cells such as neutrophils or macrophages are
capable of recognizing the invading microorganisms, and play a role in the immune
defense mechanism by oxidative activity called the respiratory burst.48 During the
respiratory burst, the consumption of oxygen is considerably increased compared to
normal conditions.49 When there is the initial inflammatory response, neutrophils are
shifted to the site of injury which activates NADH or NADPH oxidases and transfers
electrons originating from NADH or NADPH to oxygen, thus generating superoxide
radical to kill oxygen dependent microorganisms in the plasma membrane or on its outer
surface.50 Similar enzymes that produce O2•- are also present in cells other than
leukocytes. They prefer NADH to NADPH.51
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Figure 1. Formation of superoxide by xanthine and hypoxanthine
Xanthine oxidase is another popular enzyme that can also produce superoxide.
Xanthine oxidase is widely distributed in human with relatively high activity in liver and
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intestine.52,53 Xanthine oxidase is an inter-convertible form of xanthine dehydrogenase.
Under normal conditions, xanthine oxidase exists in the form of xanthine dehydrogenase
that uses NAD+ as electron acceptor, thus producing none or very insignificant amounts
of superoxide anion.54 However, upon depletion of ATP, xanthine oxidase is formed as a
result of proteolytic cleavage by a calcium-dependent protease.55 The enzyme then
sequentially catalyzes the oxidation of hypoxanthine to xanthine and xanthine to uric acid
with a large production of superoxide contributing to oxidative damages during certain
disease conditions such as ischemic-reperfusion. The superoxide anion is generated in
both oxidation steps.
Peroxidases can also generate the superoxide anion. Evidence shows that
peroxidase catalyzes the oxidation of substrates like NADH or NADPH to NAD radical
(NAD•) by using hydrogen peroxide. The superoxide anion is apparently produced by the
reduction of molecular oxygen by NAD•.56 Furthermore, the presence of certain phenols
stimulates NADH oxidation which increases the rate of the formation NAD•, thus
increasing the production of superoxide anion.57
The superoxide anion is also produced from oxidation of NADH in the presence
of a catalase.58,59 In this process, catalase probably catalyzes the oxidation of NADH to
its free radical in the presence of hydrogen peroxide. The resulting NADH free radical
(NAD•) then transfers an electron to molecular oxygen thereby producing superoxide
anion.
Catalase
NADH
H2O2

NAD• + H2O
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(8)

NAD• + O2

NAD+ + O2•-

(9)

Lipoxygenase also contributes to the formation of superoxide anion.60 The
oxidation of purine neucleotides (NADH or NADPH) catalyzed by lipoxydase in the
presence of linoeic acid lead to the generation of superoxide and might cause oxidative
stress in cells.61
Other enzymes that may be responsible for superoxide anion generation include
PGH synthase62 and cycloxygenase.63 The mechanism for these processes is similar to
that for lipoxygenase and peroxidase.
Monoamine oxidase has shown to be a superoxide anion generator in Parkinson’s
disease.64
[1.4.3] Non-enzymatic source of superoxide radical
Thiols may be responsible for the production of superoxide radical anion nonenzymatically. In biological systems, thiols such as glutathione, ethyl mercaptan, 2mercaptoethanol and dithiothreitol have shown to inhibit SOD reduction of nitro blue
tetrazolium (NBT) suggesting the formation of superoxide anion.65
Thiols undergo one-electron oxidation with the formation of thiyl radicals. The
oxidation reaction is catalyzed by transition metal ions.66 Thiyl radicals apparently react
with thiolate anion producing disulfide radical anion (RSSR•-) which loses an electron to
dioxygen yielding superoxide anion and disulfides.67
[1.4.4] Microsomes as source of superoxide radical
Superoxide anion production by microsomes has been implicated in in vivo
studies.68 Two major components in microsomes are NADPH- cytochrome 450 reductase
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and cytochrome 450 which cause the generation of superoxide. Microsomes stimulate the
NADPH-dependent SOD inhibitable oxidation of epinephrine to adrenochrome69 and the
reduction of nitro blue tetrazolium (NBT) in rat liver suggesting the formation of
superoxide anion.70 Furthermore, corticosteroids has shown to enhance the activity of
NADPH-cytochrome reductase implying the increased formation of superoxide anion.71
[1.4.5] Cell nuclei as a source of superoxide radical
Cell nuclei may also be the source of superoxide anion formation. The generation
of superoxide anion by cell nuclei was based on the oxidation of epinephrine in the
presence of NAHD-cytochrome reductase which was inhibitated by superoxide dismutase
(SOD).72,73 On the basis of the location of cell nuclei, superoxide formation is NADH- or
NADPH-dependent. The generation of superoxide anion by the nuclear membrane may
cause human malignant brain tumors.74
[1.4.6] From nitric oxide synthase
Superoxide anion is also generated by nitric oxide synthase (NOS) in the presence
of calcium/calmodulin. Upon binding of calcium/calmodulin to NOS, electrons derived
from NADPH transfer from flavin-containing reductase to heme-containing oxidase
domains of NOS to activate the enzyme. However, dissociation of ferrous-dioxygen
complex, formed by binding of oxygen to the heme group, may occur to generate
superoxide anion instead of forming water.75
[1.5] Formation of secondary free radicals
Superoxide can undergo spontaneous dismutation by non-enzymatic or enzymatic
pathways to hydrogen peroxide which is less reactive and stable than superoxide anion.
Superoxide dismutase (SOD) is an enzyme which catalyzes the dismutation of superoxide
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anion in biological systems at the rate that is four orders of magnitudes.
•-

2O2 + 2H

+

SOD
H2O2 + O2

(10)

Superoxide dismutase (SOD) contains certain metals such as copper, zinc and
manganese which act as a catalyst for the SOD-mediated disproportionation of O2•- in the
cytosol by Cu/Zn-SOD enzyme, and mitochondria by Mn-SOD enzyme.76 Hydrogen
peroxide is known for its capacity to cross the cellular membrane and to diffuse.
Hydrogen peroxide is also produced by peroxisomes particularly in liver under
physiological conditions.77 Damage to fatty acids has been attributed to the hydrogen
peroxide production other than in liver.
The resulting hydrogen peroxide is then removed by three general mechanisms.
In the cytosol, two enzymes named catalase and glutathione (GSH) peroxidase are
known to catalyze the dismutation of hydrogen peroxide into water and oxygen78 while in
the mitochondria glutathione peroxidase alone accelerates this process:
2H2O2

H2O + O2

(11)

Catalase resides within the microbodies like peroxisomes which contains four
porphyrin heme (iron) groups that catalyzes the enzyme-mediated degradation of the
hydrogen peroxide primarily produced from fatty acids and amino acids.
Glutathione peroxidase requires reduced-glutathione, a tripeptide (N,N-L-γglutamyl-cysteinglycine (GSH), to dismutate hydrogen peroxide into water and oxygen
which is then oxidized to disulfides GSSG.79 The oxidized form of glutathione is then
reduced back to GSH by the enzyme glutathione reductase in the presence of NADH
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which is supplied by a metabolic source. The process of reduction can be classified as a
detoxification mechanism.
glutathione peroxidase
2 GSH + 2 H2O2

2 H2O + O2 + GSSG

(12)

In the second mechanism, hydrogen peroxide can undergo Fenton-like reactions
to produce the hydroxyl radical (HO•) in the presence of a transition metal such as iron or
copper.80 The hydroxyl radical reacts rapidly with biomolecules resulting in the formation
of carbon-centered radical which is more stable and longer-lived. Normally, iron exists
predominantly in its oxidized ferric state form (Fe3+). The reduction of Fe3+ to Fe2+ is a
very important biochemical step to initiate the Fenton-like reaction.81,82 In the first step,
superoxide radical anion acts as a reducing agent for reduction of coordinated Fe3+ to
Fe2+. In the second step, this reduced form catalyzes the decomposition of hydrogen
peroxide into hydroxyl radical. The overall reaction is also called the Haber-Weiss
reaction.83
Fenton reaction:
O2•- + Fe3+

Fe2+ + O2

(13)

Fe2+ + H2O2

HO• + Fe3+ + OH-

(14)

Haber-Weiss reaction or net reaction:

O2•- + H2O2

Fe2+
O2 + HO• +

OH-
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(15)

The iron cations are strong oxidants which govern iron reactivity in the Fenton
reaction, and contribute to the final oxidative damages in biological systems.84,85 Because
of the toxicity of iron, living organisms carefully sequester iron in safe complex forms
and carefully release it as a micronutrient.
In the presence of chloride, hydrogen peroxide is also decomposed by an enzyme,
myeloperoxidase (MPO) into hypochlorous acid (HOCl). The decomposition process
occurs in neutrophils86 and in monocytes. Hypochlorous acid is a strong oxidant that can
damage biomolecules directly and by decomposing to chlorine. Therefore, this
mechanism is considered to be a process leading to the formation of a toxic physiological
agent. The resulting hypochlorous acid reacts with hydrogen peroxide to form a nonradical oxidant such as singlet oxygen and water.87,88 Similarly, hydrogen peroxide can
form hypobromous acid by the action of the enzyme eosinophil peroxidase (EPO)89.
These hypohalous acids are capable to produce hydroxyl radical by reacting with the
superoxide radical anion:
H2O2 + XH2O2 + HOX
HOX + O2•-

HOX + H2O

(16)

H2O + H+ + X- + 1O2
HO• + X- + O2

(17)
(18)

Apart from these reactive oxygen species, another biologically significant free
radical is nitric oxide (NO•). Nitric oxide (NO) is produced in biological tissue by the
semi-essential amino acid L-arginine via the action of nitric oxide synthase (NOS) by a
five electron oxidative reaction to form L-citrulline.90 In the cardiovascular system, NO is
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produced primarily by endothelial cells while certain nerves, blood cells, and vascular
smooth muscle cells are also capable of producing nitric oxide. The activity of NO is
controlled by cytokines which connect the immune system with the cardiovascular,
nervous and endocrine systems. Therefore, when there is an urgent need for cell defense,
immune cells can make large amounts of nitric oxide.91
Nitric oxide (NO) is a very unstable molecule and has a half-life of only a few
seconds under physiological conditions. During the oxidative burst, NO reacts
spontaneously with superoxide radical anion produced by immune cells to generate a
more oxidatively active molecule, the peroxynitrite anion (ONOO-). The formation of
peroxinitrite is regulated by the concentration of NO. It is produced when the level of NO
is very high and dismutation by SOD is inhibited. In acidic medium, peroxynitrite anion
is protonated to afford peroxynitric acid which can react with organic molecules.
Spontaneous decay of ONOOH by heterolytic cleavage generates hydroxyl radical (HO•)
and nitrogen dioxide radical (NO2•).92 The decomposition reaction is catalyzed by the
transition metal of SOD and myeloperoxidase which continues to give nitrates as a final
product:93
NO• + O2•-

ONOO-

(18)

ONOO- + H+

ONOOH

(19)

ONOOH

HO• + NO2•

(20)

HO• + NO2•

NO3- + H+

(21)
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Peroxinitrite

and its protonated form, (ONOOH), can react with selective

biomolecules such as protein thiols, zinc fingers, and membrane lipids by a one or two
electron oxidation process and eletrophilic nitration.94 This reaction is accelerated by
carbon dioxide.95 Moreover, the formation of hydroxyl radical by peroxynitrite has a
minor role in vivo because of an affinity of peroxynitrite towards carbon dioxide.
Peroxynitrite reacts rapidly with carbon dioxide to form an unstable molecule,
nitrosoperoxycarbonate (ONOOCO2-), which spontaneously homolysis into carbonate
radical anion (CO3•-) and nitrogen dioxide radical (NO2•).96
[1.6] Mechanism of free radical-mediated tissue damage
When the balance between the rate of formation of free radicals and the rate of
their scavenging is disturbed, the damage of tissues and their structures is inevitable. In
particular, hydroxyl radical is the most powerful reactive species of oxygen and can react
with lipids, DNA and proteins. Because of its strong reactivity, tissue damages occur at
the site of its formation.
[1.6.1] Free radicals in lipid peroxidation
Polyunsaturated fatty acids are among the major targets of radical-mediated
damages among othose that involve free radical chain reactions. The presence of a
methylene group between double bonds makes polyunsaturated fatty acids susceptible to
oxidation with the formation of a conjugated diene bond. The oxidation reaction first
generates a second radical, which in turn reacts with another macromolecule and
continues the chain reaction.
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Figure 2. Schematic mechanism of lipid peroxidation of polyunsaturated fatty
acids
The hydroxyl radical first abstracts a hydrogen atom from polyunsaturated fatty
acids of cell membranes and initiates the chain reaction of lipid peroxidation by
generating an alkyl radical (figure 1). The alkyl radical then reacts with oxygen to form
an alkyl peroxyl radical, which in turn, abstracts a hydrogen atom from another fatty acid
to propagate the chain reaction. A number of products are formed from lipid peroxidation
once newly formed lipid peroxides react with metals such as malondialdehyde (MDA)
and 4-hydroxynonenal (HNE)97. These aldehyde products are electrophilic and can react
with nucelophilic sulfhydryl moieties like those in cysteine, and amino acids residues
such as histidine and lysine.98 Lipid peroxidation modifies both the structure and function
of cell membranes.99
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The hydroperoxyl radical (HOO•), the conjugate acid of superoxide anion, may
also participate in fatty acid peroxidation initiation in vivo by abstracting a hydrogen
atom from the methylene group of unsaturated fatty acids.100
[1.6.2] Free radicals in DNA damage
The hydroxyl radical can also react with DNA by addition to double bonds and
abstracting hydrogen atoms especially from bases. It can also react with the deoxyribose
backbone. The consequences of these reactions are modification of individual nucleotide
bases, single-strand breakage, DNA-protein cross links, and chromosomal rearrangement.
Addition of hydroxyl radical to pyrimidines101 (thymine and cystosine) and purines102,103
forms hydroxyl pyrimidines and hydroxyl purines respectively. Hydroxyl radical reacts
with guanine bases to form 8-oxo-7-hydo-29-deoxyguanosine.104,105 Malondialdehyde
(MDA), one of the products of lipid peroxidation, can also react with DNA bases causing
mutation and cancer.106
The peroxynitrite anion also causes oxidative DNA damage as well as nitration of
DNA bases.
[1.6.3] Free radicals in protein damage
Proteins are also sensitive to oxidation reactions especially with hydroxyl radicals
formed upon exposure to ionization. Abstraction of an alpha hydrogen atom by hydroxyl
radical from any one of the amino acid residues or the peptide backbone leads to carboncentered radicals (alkyl radical), which upon addition of oxygen under aerobic conditions
forms alkylperoxyl radicals. The alkyperoxyl radical then interacts with the protonated
form of superoxide radical anion (HO2•) thus leading to an alkyl peroxide that, in turn,
further reacts with HO2• to give a protein alkoxyl radical which can cause peptide bond
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cleavage.107 These newly formed protein alkyl-, alkylperoxyl- and alkoxyl- radicals can
abstract hydrogen atoms from amino acid residues in the same or different protein and
continue the same reaction.107 The hydroxyl radical generated by the Fenton reaction can
also initiate the same reaction in the absence of ionizing radiation causing loss of
histidine residues, 108 loss of tyrosine residues, and bityrosine cross-links.109 On the other
hand,

protein-peroxyl

radicals

can

undergo

scission

and

produce

carbonyl

compounds.110,111 Peroxynitrite anion is another reactive species that can react with
amino acids residues of proteins and modify their structures and thus affect their
functions.112,113
[1.7] Biological defense against free radicals
The toxic action of free radicals from a variety of sources has led to the
development of a series of defense mechanisms within organisms to decrease or eliminate
the damage they inflict.114 Defense mechanisms against the negative influence of free
radicals include, mechanisms preventing the formation of free radicals, repair
mechanisms of damaged cells, physical defenses, and antioxidant defenses. From the
biological standpoint, an antioxidant is any substance that prevents oxidation of other
molecules by oxidants while it is itself oxidized to a relatively stable compound either in
a radical or non-radical form, that can stop the propagation radical reaction. Superoxide
dismutase (SOD), glutathione peroxidase (GPx) and catalase (CAT) are enzymatic
antioxidants. Glutathione (GSH) is a non-enzymatic antioxidant.
When the level of superoxide anion is elevated, cells rapidly synthesize SOD
enzymes to dismutate superoxide radical anion. Manganese superoxide dismutase
(MnSOD) is associated with DNA which would behave like a “tethered antioxidant.”
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Hence, MnSOD would enhances DNA protection from oxidative events and even inhibits
carcinogenesis.115 Copper-zinc superoxide dismutase (CuZnSOD) is unusually stable and
is the most important intracellular antioxidant. Among metals, copper appears to be
involved in the dismutation process by oxidation and reduction reactions whereas zinc
helps in the enzyme stabilization but does not participate in dismutation.116
Enzyme-Cu2+ + O2•Enzyme-Cu+ + O2•- + 2H+

Enzyme-Cu+ + O2
Enzyme-Cu2+ + H2O2

(22)
(23)

Deficiency of SOD increases the risk of tissue damages and causes morphological
disorders. On the other hand, increased SOD expression also has a deleterious effect on
mammalian cells.
In physiological conditions, free radical and non radical species exist at low and
measurable concentration.117 Cells maintain the concentrations of these free radical
species by establishing equilibrium between the rate of their generation and removal.118
Each cell function is characterized by the oscillation of electrons stored (redox state) in
many cellular constituents.119 Under oxidative stress conditions, glutathione peroxidase
(GPx) removes hydrogen peroxide thereby forming glutathione disulfide at the expense
of glutathione (GSH); this in turn, increases the formation of protein mixed disulfide.120
Oxidized glutathione is then stored inside cells and this will increase the ratio of reduced
(GSH) to oxidized glutathione (GSSG). However, too high concentrations of GSSG may
damage many enzymes oxidatively. Cells will then remove oxidized glutathione disulfide
by the activity of glutathione reductase in the presence of NADPH to maintain the redox
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state as represented by the oxidized (GSSG)/ reduced (GSH) ratio.121 The ratio of
oxidized and reduced glutathione is a measure of oxidative stress within an organism.
GSSG + NADPH + H+

2GSH + NADP+

(24)

The Nernst equation can be used as a tool to estimate a reduction potential from
reducing capacity, which is the concentration of the reduced species. Both of these
factors are important to determine the redox state of the cell.119
Catalase, similar to glutathione peroxidase, eliminates hydrogen peroxide
generated from dismutation of superoxide anion. In addition to its role as a cofactor of
glutathione peroxidase, glutathione is involved in many other metabolic phenomena.
Gluthathione inhibits the ability of copper ion to generate free radicals by chelation.122 It
can quench certain free radicals and non- radicals such as HO•, RO•, RO2•, R•, and
peroxynitrite anion. However, the reaction with a radical would generate the thiyl radical
(GS•) which may generate superoxide anion. In such case, SOD might assist GSH in the
elimination of free radicals. Moreover, GSH reacts with peroxynitrite anion to form
nitrosothiol, which leads to the regeneration of nitric oxide. This is an important process
in the protection of cells from deleterious effects of peroxynitrite.
Similarly, the formation of NO can act as direct feedback inhibition of NOS for
further synthesis of NO.123
[1.8] Role of free radicals in various diseases
Oxidative stresses caused by free radicals have been implicated in various
pathological conditions. The involvement of free radicals in disease is triggered by
various factors such as genetic, environmental and disturbance of metabolic systems.
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Free radicals produced in mitochondria are widely believed to be the major cause of
manifestation of a pro-oxidative shift in the plasma thiol/disulfide redox state which
impairs glucose tolerance. These conditions are generally observed in cancer124 and
diabetes.125 As in the other cases, the enhanced activity of NAD(P)H oxidase and
xanthine-oxidase are the major cause of ROS generation derived from superoxide anion.
These conditions are normally observed in chronic inflammation126 and ischemia/
reperfusion injury respectively.
An alteration of cellular thiol/disulfide redox state as a result of oxidative stress
has been found in many cancer cells. Damage to DNA, occurs because free radicalinduced permanent modification of genetic materials, thereby leading to cell mutagenesis
and carcinogenesis.127 An increased level of DNA damage has also been found in tumors
which suggest the involvement of oxidative stress in the etiology of cancer. If DNA is
severely damaged, then affected cells are selectively eliminated by the process called
apoptosis.128 Apoptosis, a normal biological process, is a programmed cell death that
destroys the damaged cells that could otherwise cause a threat to the integrity of
organisms by leading to many morphological changes.129 However, uncontrolled
apoptosis can lead to the destruction of healthy cells.130 The consequences of DNA
damage are arrest or induction of transcription, induction of signal transcription
pathways, genomic instability, and replication error; all of them are associated with
carcinogenesis.131,132 The formation of the DNA oxidation product, 8-oxo-7-hydo-29deoxyguanosine (8-oxo-dG), has been studied most extensively as a potential biomarker
of carcinogenesis because it is easily detectable. 8-oxo-dG was first detected in urine by
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Shigenaga et al133 Tobacco smoking is one of the sources of carcinogenic reactive oxygen
species.134
Free radicals are also involved in diabetes mellitus.29,135 Hyperglycemia is the
common characteristic of both type-1 diabetes mellitus (insulin-dependent) and type-2
diabetes mellitus (non-insulin-dependent). Hyperglycemia is the condition in which an
excessive amount of glucose is circulated in the blood plasma. Increased glucose levels
are shown to increase the production of free radicals from various sources. The major site
of superoxide anion formation in diabetes is mitochondrial complex II136 which is
different from the sites mitochondrial complex I and the ubiquinone-complex III that
generate superoxide anion under normal conditions. Glucose auto-oxidation has been
shown to produce superoxide anion in diabetic patients137,138 The advanced glycation end
(AGE) products are the result of glucose oxidation which interact with specific cell
surface binding proteins with subsequent generation of reactive oxygen species (ROS).139
The increased level of ROS may cause the development of diabetic complications such as
accelerated atherosclerosis140 and other vascular pathologies.141
Various inflammatory diseases are associated with the elevated production of
reactive oxygen species.142 Atherosclerosis is one of the chronic inflammatory diseases
that is characterized by hardening and thickening of the arterial walls that develop in the
inner coat.143 In the presence of hyperlipidemia, oxidative stress may activate the genes
that induce an inflammatory response to the vascular endothelium. The injured
endothelial cells then stimulate the recruitment of mononuclear cells into the arterial
walls which bind oxidized low-density lipoprotein (LDL) resulting in abnormal
macrophages, that subsequently undergo apoptosis. The massive apoptosis of
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macrophages causes the formation of atherosclerotic plaque.144 Moreover, experimental
data shows that hypertension may cause an intensification of atherosclerosis.145
A role for oxidative stress in hypertension has been supported by the study of an
animal model of hypertension by Vaziri et al. via in vivo glutathione depletion.146
Similarly, a potential causative role for oxidative stress is also found in patients with
essential hypertension.147,148 The mechanism that seems to contribute to hypertension is
increased generation of superoxide anion in the vessel wall followed by the formation of
peroxinitrite anion,149 which in turn, increases vasoconstriction.150 In vivo studies in
animals demonstrated that angiotensin II is the main factor that is involved in the
oxidative stress that leads to chronic high blood pressure.151,152
It is suggested that oxidative stress is also involved in several neurodegenerative
diseases. Nervous tissue suffers more oxidative damages than other tissue types.153
Although the brain contributes only a few percent of all tissue mass, it is the most large
amount of ATP is required to maintain normal neuronal functions. Brain has a high iron
content154 that can be released as ions during brain injury, and these ions catalyze free
radical reactions resulting in HO• formation which thereby accelerates lipid peroxidation
and autoxidation of neurotransmitters.
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by
impairment of higher cognitive functions and extensive neuronal loss. Two pathological
features found in AD patients are the accumulation of amyloid plaques (amyloid-β
peptide) in the brain and the presence of neurofibrillary tangles and neurophil threads.155
A progressive cerebral accumulation of amyloid-β peptide is the major event in the
development of Alzheimer’s disease. The accumulation of peptides causes neurofibrillary
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damage in neurons and neuronal cell death. A postmortem study of Alzheimer’s disease
brains indicated the reduction of various neurotransmitters.156 These phenomena are the
major cause of loss of cognitive functions.116 The evidence of increased lipid
peroxidation and decreased polyunsaturated fatty acids content, increased protein and
DNA oxidation, increased formation of 4-hydroxynonenal (product of lipid peroxidaiton)
in AD ventricular fluids, the presence of advanced glycation end products,
malondialdehyde, nitrotyrosine, and peroxynitrite in neurofibrillary tangles supports the
involvement of oxidative stress in the brains of Alzheimer’s disease victims.155,157 The
significant amount of lipid peroxidation has been implicated by the increased level of 4hydroxynonenal in the postmortem cerebrospinal fluid of Alzheimer’s disease patients.158
Most individuals with Down’s syndrome have been shown to develop Alzheimer’s
disease as they get older.159 The higher risk of Alzheimer’s disease in individuals with
Down’s syndrome might be as a result of the extra copy of chromosome 21 which leads
to increased production of amyloid beta. Down’s syndrome is a genetic disease that
results from three copies of chromosome 21. The syndrome leads to mental retardation,
often ranging from mild to moderate disability. A small number of individuals with
Down’s syndrome have a severe to high degree of intellectual disability. There is
evidence of over-expression of Cu/ZnSOD in Down’s syndrome that may result in
increased production of hydrogen peroxide.28 Overproduction of Cu/ZnSOD in
transfected cells appears to promote increased lipid peroxidation. 160
Parkinson’s disease (PD) is characterized by a problem in controlling movement
that includes slow movement of foot and hand when they are at rest and muscle rigidity.
Parkinson’s disease (PD) is associated with a selective loss of neurons in a part of the
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midbrain called the substantia nigra.98 The cells of the substantia nigra produce
dopamine, a neurotransmitter-chemical messenger between brain and nerve cells, which
communicates with cells in another region of the brain. It is believed that oxidative stress
is an initiator of dopaminergic cell degeneration which is also associated with the
presence of Lewy bodies in the substantia nigra and elsewhere on the basis of the
postmortem study.64,161 Lewy bodies are small spherical proteins which affect the brain’s
normal functions and interrupt the action of important chemical messengers.
Similarly, in amyotrophic lateral sclerosis (ALS), motor neurons are the main
targets affected in the motor cortex, spinal cord and brain stem162 which leads to muscle
tone impairment, respiratory failure, paralysis, and often death. Multiple mutations are
associated with familial amyotrophic lateral sclerosis. Studies show that 20 % of familial
ALS patients carry mutations in the Cu/ZnSOD gene, suggesting the involvement of free
radicals.163 One hypothesis concerning the etiology of ALS is that metals at the active
sites of mutant Cu/ZnSODs allow these enzymes to catalyse oxidation reactions via
peroxynitrite-generated

nitrating

species.164

Several

lines

of

transgenic

mice

overexpressing mutant Cu/ZnSOD have shown to develop a motor neuron disease, whose
pathology and mode of progression resemble familial ALS patients. Gurney, Becker et al.
used azulenyl nitrone (AZN) to suggest oxidative stress in SOD mutant transgenic
mice.165 Recently, Siddque’s team discovered mutation in ubiquilin 2 gene in the brains
and in the spinal cords of ALS victims.166 The mutant ubiquilin 2 gene causes the
accumulation of damaged protein contributing several forms of amyotrophic lateral
sclerosis.
Friedreich’s ataxia is an autosomal recessive genetic disorder which is caused by
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a defect in gene called Fractaxin.167 The clinical features consist of loss of position and
vibration sense in the lower limbs and dysarthria, loss of deep tendon reflexes, and
progressive limb and gait ataxia. Evidence of oxidative stress and therapeutic benefit
from antioxidants have been reported.168
Huntington’s disease (HD) is a neurodegenerative disease of autosomal dominant
inheritance which causes both movement disorder and dementia. There is evidence of
elevated levels of oxidative damage products such as malondialdehyde (MDA) and
leukocyte-8-hydroxydeoxyguanosine (8-OHdG) in Huntington’s disease patients.169
Multiple sclerosis (MS) is an inflammatory disease which affects the brain and
spinal cord. Multiple sclerosis is caused by damage to the myelin sheath which is the
protective covering of nerve cells.170 Post-mortem analysis of the brains of the MS
victims indicated the presence of nitrotyrosine which may be produced by reaction
between superoxide and nitric oxide.171
Neuronal ceroid lipofuscinoses (NCL) are a group of neurodegenerative
lysosomal storage disorders which is characterized by the progressive and permanent loss
of motor and physiological ability.172,173 It involves the progressive accumulation of the
pigments called lipofuscins in cells of the brain and other tissues. Clinically, NCLs are
defined by their age of onset and symptoms: infantile NCL (Santavuori-Haltia), lateinfantile NCL (Jansky-Bielschowsky), juvenile NCL (Batten disease, Spielmeyer-Vogt)
and adult NCL (Kuf’s disease) and epilepsy NCL (progressive epilepsy with mental
retardation). Study on cultured cell derived from patients with NCL indicated that
oxidative stress is common manifestation of neuronal ceroid lipofuscinoses.174
Injury to heart, brain, lungs, intestine, liver, kidney and skeletal muscle resulting
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from ischemic/reperfusion may present in a variety of clinical conditions such as organ
transplantation, stroke, myocardial infractions, and other situations.175-177 On the basis of
hospital discharge records, 5 million patients (16.2 %) were diagnosed with ischemic
cardiovascular events and such events were the major cause of death (38.7 %) in the
United States.178 Occurrence of tissue damage is attributed to the large amount of ROS
production during ischemia/reperfusion.179 Under the ischemic condition (oxygen
deprivation), there is depletion of adenosine triphosphate (ATP) which results in the
conversion of xanthine dehydrogenase is into xanthine oxidase that utilizes oxygen. At
the same time, cellular ATP is catabolized to hypoxanthine which accumulates in
ischemic tissue. Upon subsequent reperfusion (reoxygenation), xanthine oxidase uses the
influx of oxygen to oxidize hypoxanthine into xanthine with rapid generation of
superoxide anion and hydrogen peroxide.180 Treatment with a synthetic SOD mimetic has
been shown to attenuate tissue damage in a rat model of ischemia/reperfusion injury.181
Obstructive sleep apnea is a breathing disorder among adults, characterized by an
abnormal pause in breathing during sleep.182 The resulting repeated hypoxia and
reoxygenation is similar event to the conditions of ischemia/reperfusion. Untreated and
severely affected individuals often develop cardiovascular diseases such as coronary
artery disease, arterial hypertension and cerebrovascular disease183 that are associated
with increased mortality.184 The involvement of free radicals in obstructive sleep apnea,
which could be the cause of the associated cardiovascular events, has been implicated by
the detection of increased production of superoxide anion from polymorphonuclear
neutrophils in affected patients after exposure to various stumuli.185
Aging is a process of progressive loss in the efficiency of physical and cognitive
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functions of an organism after the reproductive phase of life.107 The fact that free radicals
cause deleterious damage to cells over time which results in aging was proposed by
Harman et al.11 Several studies also support his theory by showing progressive generation
of free radicals and almost exponential increases in accumulation of oxidatively damage
proteins, lipids and DNAs during aging.186-188 Mitochondria are the primary sites of
generation of oxidants during the aging process. Much of the oxidized DNAs, especially
the nuclear DNA, are repaired by the cell but the mitochondrial DNA receives only low
repair activity.189 Over time, the damaged mitochondrial DNA accumulates and slowly
shuts down mitochondria causing cell to age and eventually die.
[1.9] Free radicals in important physiological processes
In addition to the detrimental effects of free radicals, they are also well recognized
for their importance in vital physiological activities. It is well established that free
radicals play a role in protective signaling and regulation within the cells. Cells in
organisms communicate with each other and respond to extracellular stimuli via a
signaling mechanism called a signal transduction.190 With this biological mechanism,
cells convey the information from the outside of the cell to various functional agents
inside the cell. Signals are transferred within cells when cells are stimulated by reactive
oxygen species. Signal transduction is initiated by extracellular signals such as growth
factors, neurotransmitters, hormones and cytokines.48 The signal transduction processes
can leads to the activation of a class of proteins called transcription factors which are
responsible for the expression of genes. Through the free radicals, which are generated in
low concentration by stimulation of growth factors and hormones, the signal is
transmitted. For example, hydrogen peroxide, produced by growth factors, is found to be
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necessary for the proper functioning of signal transduction191,192 and acts as a secondary
messenger.192 However, superoxide anion appears to regulate protein tyrosine
phosphatase (PTPs) activity more effectively than hydrogen peroxide via a cysteine
residue with the formation of the cysteine disulfide.193 The formation of the cysteine
disulfide results in inactivation of the protein, which is reactivated by a specific enzyme
that reduces cysteine disulfide. The reversible regulation of PTPs indicates that free
radicals play an important cell signaling role in controlling redox balance.
Free radicals and ROS also regulate immune responses. Superoxide anion and
nitric oxide generated in neutrophils and macrophages during the inflammatory condition
plays a major role in cell defense. During inflammation, peroxynitrite anion may form
from superoxide and nitric oxide which participates in the CNS inflammatory response of
rat infected with Borna disease virus and in the host immune response to Coxsackievirus
infection.194
Superoxide and other ROS produced by NADPH oxidase of vascular cells appear
to regulate the vascular and cardiac cell functioning in rat by activating intracellular
signaling pathways.16 Free radicals are shown to be involved in the stimulation of
guanylate cyclase which catalyzes the formation of 3',5'-cyclic guanosine monophosphate
(cGMP) from guanosine triphosphate (GTP). The resulting cGMP regulates vascular
smooth muscle tone and inhibits platelet adhesion.195
Free radicals as signaling factors also regulate the monitoring of oxygen tension
in the control respiratory ventilation.196 Changes in oxygen concentration are sensed by
the regulated production of hormones such as erythropoietin and IGF-II (insulin-like
growth factors) which are controlled by hypoxia-inducible factor.196
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The involvement of free radicals in a signal preconditioning has been an
interesting subject in many studies aimed at understanding the natural protective
mechanism for ischemia in minimizing sudden cardiac death.197-200xx Preconditioning, a
condition whereby a signal increases the tolerance of tissue to ischemia/reperfusion
injury, such that a brief episode of non-lethal ischemia confers long and short term
protection against the lethality of a prolonged ischemic insult.201 Evidence shows the
beneficial effect of preconditioning in a variety of organ systems including the circulating
system.
[1.10] Detection of free radicals
Detection of free radicals began to develop soon after the discovery of the
biological importance of superoxide anion in physiology.202 Several in vivo studies on the
action of antioxidants suggested the role of free radicals and ROS as a stimulator of
inflammatory signaling and promoter of growth stimulatory signals which can lead to
several disorders.203 Therefore, in biomedical research, identification of ROS and their
sources is crucial to the development of novel drugs that function as both radical
scavenger and non-steroidal anti-inflammatory agents (which target the sites of free
radical generation). The identification of radicals will allow investigator to understand
their exact role in specific diseases as well as their formation sites and their molecular
targets. However, problems exist in the detection and quantification of intracellular
superoxide radical anion. Spectroscopic technique known as electron spin resonance
(ESR) otherwise known as electron paramagnetic resonance (EPR) were developed.
Electron spin resonance has been a powerful tool for the detection of unpaired
electrons within free radicals. Free radicals can have either + ½ or – ½ spin and therefore
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act as a small magnet.116 Electron spin resonance is the resonant absorption of microwave
radiation by paramagnetic species under the influence of an external applied magnetic
field.204 The electron magnetic moment of the unpaired electron can align itself either
parallel or anti-parallel to the field creating two energy levels which vary with magnetic
flied strength. When the applied microwave energy matches the energy level separation,
energy is absorbed and causes movement of the electron from the lower energy level to
the upper one. The absorption is monitored and a spectrum is obtained usually in the
microwave region of the electromagnetic spectrum. The degree of absorption is
proportion to the number of free radical in the substance.205 The equation to obtain
absorbance is:
∆E = gβH

(22)

where ∆E is a the energy gap between the two energy levels of the electron, g is a
gyromagnetic ratio of the electron whose value for the free electron is 2.00232 (most
biological free radicals have value close to this), β is the Bohr magneton and H is the
applied magnetic field. The number of lines in the ESR spectrum of a radical is known as
the hyperfine structure. The presence of many nuclei in radicals makes it often very
complicated. Generally, a radical is identified by calculating the g value, hyperfine
structure and line shape.
Although a promising instrument, the ESR is insensitive for direct detection of
free radical such as superoxide radical anion and hydroxyl radical in living system. Direct
detection of intracellular superoxide radical by spectroscopic observation is difficult or
virtually impossible because of its exceptionally short lifetime, low concentration and
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rapid intracellular reactions. Direct detection of biological free radicals is only possible
with high concentrations of free radicals or if low temperature is used to minimize their
reactions. For example, at exceptionally low temperature, ESR was able to detect the
hydroperoxyl radical (HO2•) in argon at 4.2oK directly.206 The hydroperxyl radical was
generated by addition of hydrogen atom to oxygen. In another experiment, Saito207 and
Czapski208 have reported using ESR to detect HO2• by forming a metal complex.
However, these approaches limit the detection of biologically generated free radicals. To
overcome this difficulty, the spin trapping approach was developed. In this technique, a
radical is allowed to react with a spin trap molecule to form a more stable radical product,
detectable by ESR, which provides a spectrum characteristic for the particular free radical
that is trapped. The spin trapping method to detect short-lived radicals was first pioneered
by Janzen et al.209 With the advent of ESR spectroscopy and the spin trapping method, it
is now possible to identify free radicals produced at physiological temperatures. Spin
trapping methods have proved to be a very useful tool in detecting superoxide radical
anion both in vivo and in vitro detection. In addition to spin trapping, other techniques
have also been employed for the detection of free radicals particularly superoxide radical
anion, which will be discussed in a subsequent section.
[1.11] Nitrones
The term “nitrone” is a concise word that describes compounds derived from
nitrogen ketone compounds. The name nitrone was first given by Pfeiffer in 1916 to a
class of compounds containing a nitrogen-oxygen linkage (N→O) in order to indicate the
chemical similarity to carbonyl compounds.210 Later, in 1938, Smith

211

reviewed those

compounds and redefined nitrone as a class of compounds for both open and closed
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chains containing the group below:

N

O

1
There are a variety of methods to synthesize these nitrones such as direct
alkylation of oximes, oxidation of N,N-disubstituted hydroxylamines, thermal
isomerization of oxaziranes, and from carbonyl and nitroso compounds.212 Nitrones have
a remarkable ability to undergo nucleophilic addition

213

and 1,3-dipolar cycloaddition

reactions.214 Because of these properties, nitrones have received special attention as
building blocks in the synthesis of various natural and biologically active compounds as
well as for their application in radical trapping studies (including those that takes place in
biological systems).215
The compounds containing the nitrone moiety have demonstrated a potential
therapeutic activity in both in vivo and in vitro studies.216,217 In addition, nitrones have
also been useful for detection of free-radical mediated oxidative stress in biological
systems.217 Up until now, many nitrone-containing molecules have been developed, and
examined for their efficacy as antioxidants and as potential tools for superoxide anion
radical detection.
[1.11.1] Synthesis of biologically important nitrone-based spin traps
Acyclic nitrones can be synthesized directly by condensation of N-
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monosubstituted hydroxylamines with carbonyl compounds. The most widely tested
nitrone, α-N-phenyl-N-tert-butylnitrone (PBN), and its derivatives have been synthesized
by using this method of preparation.218

O
O

N

NHOH

H

2 PBN
Azulenyl nitrone (AZN) is a new class of acyclic nitrone first prepared by Becker
et al. by condensing N-tert-butyl hydroxylamine with an azulenyl aldehyde derived from
guaiazulene.219 Studies of AZN in animal models showed a therapeutic benefit against a
number of diseases and utility as biomarker of free radical events.165,217,220
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Using the same protocol, STAZN, a second generation azulenyl nitrone was
synthesized.221 Recently, in studies conducted by researchers at the Salk Institute,
STAZN was deemed an emerging therapy for ischemic stroke. Its mode of action,

35

according to these researchers, may be pleiotropic.222 Ginsberg and Becker et al. reported
several papers that documented the beneficial effects of STAZN for stroke in animal
models.223-226
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Heteroaryl-nitrone molecules, in which the carbon of the nitrone moiety has a
heteroaromatic substituent, can be prepared by various methods227

including N-

alkylation of oximes,228 and condensation of active methylene compounds with nitroso
compounds.229
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Cyclic nitrones have also received much attention-specially for the superoxide
detection. Cyclic nitrones are usually prepared by reductive cyclization between carbonyl
and nitro functional groups. First, the nitro group is reduced to the hydroxylamine with
zinc and aqueous ammonium chloride, which is followed by intramolecular condensation
with the carbonyl moiety form a ring.230 Many pyrroline N-oxide derivatives were made
by this method.231-233

Zn/NH 4 Cl

NO 2

N
O

O

7
It is also possible to prepare nitrones by oxidizing amines and imines. Bernotas et
al. have made a cyclic analog of PBN, MDL-101,002, and other derivatives, by catalytic
oxidation of imines with hydrogen peroxide.234,235
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The subsequent nitrone can be a precursor for the synthesis of another nitrone. For
instance, MDL-108,881 was prepared by nucleophilic addition followed by oxidation.236
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Some highly substituted nitrones have been synthesized by oxidation of
amines.237
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[1.12] Methods for superoxide radical detection
[1.12.1] Nitrones as spin traps for superoxide radical detection
The spin trapping technique commonly consists of using one of two classes of
compounds; namely, nitroso compounds and nitrones. Reaction of unstable radicals with
nitroso compounds and nitrones often formed a long-lived nitroxide radical which is also
called an aminoxyl radical or spin adduct. The nitroxide adducts so formed are detectable
by ESR spectroscopy.
R
R

N

+

O

O

N

R'

R'

nitroso compound
“spin trap”

reactive
radical
+

N

nitroxide radical
“spin adduct”
N
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O

nitrone “spin trap”

R

reactive
radical

nitroxide radical
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Figure 3. Spin trapping of a free radical with nitrone and nitroso compound
Nitroxide radicals are fairly stable because of the delocalization of the electron
between the nitrogen and oxygen.
N

O

+

N

O

Figure 4. Resonance stablization of spin adduct
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In nitroso compounds, the free radical directly adds to the nitrogen atom. The
resulting spin adducts displays hyperfine nitrogen splittings because of the trapped
radical whereas, in nitrone spin traps, the radical detected by ESR is influenced by the
carbon adjacent to the nitrogen atom (because the free radical adds to the adjacent
carbon). However, spin adducts obtained from nitroso compounds are often less stable,
especially when oxygen-centered radicals are trapped compared to those obtained from
nitrones. Furthermore, nitroso compounds are toxic are are thus less frequently used in
biological systems. As a result of undesirable features, nitrones are preferred in biological
systems despite the fact that spin adduct from nitroso compounds give better structural
informations from ESR than do those from nitrones.
In early work, two kinds of spin traps have been developed, the five membered
cyclic nitrone, 5,5-dimethyl-3,4-dihydro-2 H-pyrrole N-oxide (DMPO), and linear
nitrones such as α-N-phenyl-N-tert-butylnitrone (PBN) and N-[(1-oxidopyridin-1-ium-4yl)-methylidene]-1,1-isopropylamine (PyOBN). Of these, the linear nitrones PBN and
PyOBN were found to be very inefficient in detecting superoxide anion by ESR.238,239 αN-phenyl-N-tert-butylnitrone (PBN) traps superoxide anion to form the superoxide spin
adduct (PBN-OOH), which is highly unstable and decays into its corresponding hydroxyl
adduct (PBN-OH) which also suffers a decomposition reaction. The kinetic studies
showed that the rate of decay was first-order.240 The half-life of the hydroxyl adduct is 38
s while that of the superoxide adduct is even less than that at neutral pH.241 Therefore,
the ESR spectra of these superoxide spin adducts are not very characteristic of the radical
trapped. To improve their efficiency, efforts were made by elaborating phosphorylated
analogues and replacing methyl group with ester moieties.242,243 However, no better
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results have been observed in trapping superoxide with these derivatives despite the fact
that they are efficient at trapping carbon-centered radicals. A kinetic study conducted by
Tuccio et al demonstrated that cyclic nitrones are incomparably better at detecting
superoxide anion that was than the linear nitrones.244

O
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N
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N

N
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O

11 DMPO

12 PBN

13 PyOBN

Figure 5. Structures of DMPO, PBN and PyOBN
5,5-dimethyl-3,4-dihydro-2 H-pyrrole N-oxide (DMPO) is a cyclic nitrone the
first to be used. It has been used as such for decades. Bonnett et al. first prepared DMPO
as a model molecule towards the synthesis of corrins, which is the parent macrocyclic
component of vitamin B12.245 The spin trapping property of DMPO with carbon-centered
radicals was first examined by Iwamura et al. in 1967.246 The spin adduct formed from
the reaction was found to be very unstable. Later, Janzen et al. demonstrated the ability of
DMPO to trap oxygen-centered radicals.247 It was Harbour et al. who first brought
attention to the use of DMPO for the detection of superoxide radical.248 DMPO indeed
can trap superoxide radical to produce a relatively stable DMPO-superoxide adduct
(DMPO-OOH).
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Figure 6. Reaction of DMPO with superoxide radical
The ESR spectrum of the spin adduct consists of hyperfine splitting because of
the β–hydrogen and the nitroxide nitrogen. The hyperfine coupling constant of DMPOOOH was reported as: AN = 14.34 G, AHβ = 11.7 G, AHγ = 1.25 G (gauss).249 However,
the DMPO-OOH adduct was found to be unstable and spontaneously decomposes into
the DMPO-hydroxyl adduct (DMPO-OH) and a non radical species.238 The stability of
DMPO-OOH is pH dependent. Butterner and Oberley have reported the half-life of
DMPO-OOH in the range of 27s and 91 s at pH 9 and pH 5 respectively.250 It has been
reported that a cyclic nitroxide radical possessing an α-hydrogen atom tends to
disproportionate rapidly.251 The hyperfine coupling constant of DMPO-OH is AN =
14.874 G and AH = 14.81 G (gauss). On the basis of a kinetic study, the second order rate
constant for the reaction of DMPO with superoxide is only 10 M-1s-1 while that with
hydroxyl radical is approximately 2 x 10 M-1s-1.252 Glutathione peroxidase, which is
present in most cells rapidly catalyzes the decomposition reaction. As a result, the
superoxide dismutase-inhibitable formation of DMPO-OH was monitored for superoxide
detection. However, the detection of DMPO-OH leads to misinterpretation of the free
radical actually trapped because DMPO efficiently reacts with hydroxyl radicals to
produce DMPO-OH adducts. Hence, the detection of DMPO-OH does not unequivocally
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provide evidence for the identification of the hydroxyl radical either. Reaction of DMPO
with neutrophils superoxide anion gave a number of EPR spectra including that of
DMPO-OH while the experimental study demonstrated no evidence of hydroxyl radical
in human neutrophil.253 To overcome these drawbacks of DMPO, several DMPO-type
analogues have been developed. These spin traps include the alkoxy-phosphorylated
analogues: 5-diethyoxyphosphoryl-5-methyl-1-pyroline N-oxide (DEPMPO)254 and 5diisopropyloxyphosphoryl-5-methyl-1-pyroline N-oxide (DIPPMPO).255 As expected, the
spin adduct DEPMPO-OOH and DIPPMPO-OOH did not decompose into the
corresponding hydroxyl adduct and have higher persistency compared to DMPO-OOH.
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Figure 7. Structures of DEPMPO, DIPPMPO, EMPO and BocMPO
The first ESR evidence of superoxide generation, in ischemia/reperfusion of isolated rat
myocardium, has been detected by using the DEPMPO spin trap.256 However, superoxide
detection using DEPMPO and DIPPMO remains limited in biological systems because of
the confounding ESR spectrum because of an additional
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P hyperfine coupling, the

existence of diastereomers, and formation of ESR silent products.
Since the presence of an electron withdrawing dialkoxy-phosphoryl moiety in the
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β-position of the nitrone function stabilizes the superoxide adduct, investigators have
turned to

the synthesis of alkoxy-carbonyl nitrones, 5-ethoxycarbonyl-5-methyl-1-

pyroline N-oxide (EMPO),257 its isotpoically labeled nitrone (15N) EMPO,232 and 5-tertbutoxycarbonyl-5-methyl-1-pyroline N-oxide (BocMPO or BMPO). The presence of an
ester function in EMPO and (15N) EMPO improved the ESR signal to noise ratio and
increased the stability of its superoxide adduct (EMPO-OOH) compared to that of
DMPO-OOH. Moreover, EMPO-OOH did not decompose into its corresponding adduct
EMPO-OH. However, the major disadvantage of EMPO is that EMPO-OOH decays
faster than DEPMPO-OOH. The relative half-life of EMPO-OOH is 8 min while that of
DEPMPO-OOH is 14 min. Steric hindrance may play a role in the stability of nitroxide
molecule.258 In terms of stability of the superoxide adduct, BMPO-OOH is slightly more
stable than EMPO-OOH. Similar to EMPO-OOH, BMPO-OOH does not decay nonenzymatically to the BMPO-OH adduct. The time-dependent change in ESR spectra
demonstrated that BMPO-OOH adduct could be detected even up to 35 min while the
EMPO-OOH signal intensity was not detectable at this time-point. The BMPO-derived
adduct also provided a higher signal to noise ratio in biological systems. Even with these
ideal characteristics, it has some limitations. For instance, the enzyme glutathione
peroxidase can readily decompose BMPO-OOH into BMPO-OH adduct, making the ESR
spectrum difficult to interpret in biological systems. The rate constant for the superoxide
trapping reaction of EMPO was reported three times higher than BMPO at pH 7.2 which
indicates that EMPO is superior to BMPO.243 At the same pH, the rate constant of BMPO
is fairly equal to DEPMPO, but at pH 7.4, the rate constant of DEPMPO is twice as
much as BMPO259 suggesting DEPMPO is twice as efficient as BMPO at trapping
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superoxide. One of the problems of using DEPMPO is that it decomposes on heating
which makes its preparation in high purity very difficult.
Despite the tremendous efforts in developing new ESR suitable nitrone spin traps
to improve spin trapping of superoxide, the intracellular detection of superoxide using
ESR spectroscopy remains a big challenge. Several groups have turned to other
techniques for superoxide detection.
[1.12.2] Chemilumigenic probes for detecting superoxide radical
In the chemiluminescence-based technique, a chemiluminescent probe, upon
exposure to superoxide anion, emits a photon, which, in turn, can be detected by a
luminometer or scintillation counter. The sensitive measurement of the emitted photons
reflects the biological production of superoxide. The possibility of detecting superoxide
N
NH2

O
NH
NH

N

O

18 Lucigenin (DBA++)

19 Luminol

Figure 8. Structures of lucigenin and luminol
by use of a chemiluminescent probe came from Totter et al.,260 who postulated that
oxygen radicals in the reaction caused emission of light. Later, Fridovich261 demonstrated
the involvement of superoxide anion in the system of xanthine oxidase/xanthine and a
chemiluminescent compound leading to the emission of light.
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The most widely used compound in this study was bis-N-methylacridimium
nitrate (lucigenin or DBA++) because of its sensitivity. Lucigenin is cell permeable,
hence, detected superoxide reflects both intracellular and extracellular superoxide
production.

Lucigenin-derived chemiluminescence has been used in the specific

detection of superoxide formation by in vitro isolated enzymes, vascular tissue262 and
inflammatory cells, such as neutrophils and macrophages.263 It has also been used as an
indicator of superoxide production in numerous disease conditions such as various form
of hypertensions,264 diabetes mellitus,265 and hypercholesterolemia.266 It is also possible
to detect mitochondrial superoxide production by using lucigenin.267
Other

chemiluminescent

compounds

include

5-amino-2,3-dihydroxy-1,4-

phthalazinedione (luminol) and cypridina luceferin analogs such as 2-methyl-6-phenyl3,7-dihydroimidazo (1,2- )-pyrazin-3- one (CLA), 2-methyl-6-(p-methoxyphenyl)-3,7dihydroimidazo

(1,2- )-pyrazin-3-one

(MCLA),

and

2-(4-hydroxybenzyl)-6-(4-

hydroxyphenyl) 8-benzyl-3,7-dihydroimidazol[1,2- ]pyrazin-3-one (coelenterazine).268
Luminol is oxidized by various ROS such as hydrogen peroxide, hydroxyl radical,
peroxynitrite, and hypochlorous acid besides superoxide anion. MCLA has also shown to
emit light in response to hydroxyl radical and other ROS.269 Thus, these molecules are
not specific for detecting superoxide anion.
The potential mechanism of reaction of lucigenin with superoxide anion is
illustrated in Fig. 2. Lucigenin first undergoes one electron reduction by superoxide anion
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Figure 9. Reaction between lucigenin and superoxide radical
to produce lucigenin cation radical which, in turn, reacts with a second molecule of
superoxide

anion

to

yield a highly

unstable energy-rich lucigenin dioxetane

intermediate.270 The lucigenin dioxetane finally decomposes to produce two molecules of
N-methylacridone, one in an exicited state, which relaxes to the ground state by emitting
photons. By measurement of the photon emission, superoxide production in biological
systems can be detected.
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However, the credibility of lucigenin-derived chemiluminescence for biological
superoxide detection has been criticized because superoxide production might be
incorrectly detected as a result of a phenomenon called redox cycling.4 It turned out that
in in vitro enzymatic systems, lucigenin itself can produce superoxide via autoxidation of
lucigegnin cation radical5 (Fig. 3). The reaction is accelerated by flavin containing
enzymes such as xanthine oxidase, endothelial NO synthase, and cytochrome P450
monooxygenases. Furthermore, the autoxidation reaction depends on the concentration of
superoxide anion. If the biological superoxide anion level is low, the relative contribution
of superoxide via redox cycling to the measured superoxide anion will be higher than the
contribution when biological superoxide level is higher. Several groups reported that
redox cycling depends on the concentration of lucigenin. At higher concentration,
lucigenin reacted with several flavin containing enzymes to generate superoxide anion
but at low concentration it failed to stimulate superoxide generation. If lucigenin has to
be used to detect superoxide anion under a particular condition, a safe non- redox cycling
concentration of lucigenin has to be determined by either the measurement of stimulation
of oxygen consumption by oxygen polarography or detection of stimulation of
superoxide production by the DEPMPO spin trap.271 Thus, this experiments suggests that
to validate the result obtained from lucigenin-derived chemiluminescence, a second
method has to be used for confirmation.
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Figure 10. Formation of superoxide anion from lucigenin cation radical
[1.12.3] Fluorescent probes for detecting superoxide radical
The fluorescence-based technique has been widely used for in vitro and in vivo
detection of superoxide anion. Recently, the most popular fluorogenic probe used for
detecting intracellular superoxide production is hydroethidine (HE), also known as
dihydroethidium (DHE) and its mitochondria-targeted analogue (MitoSox red), in which
the ethyl group of hydroethidine was replaced by a triphenylphosphonium moiety to
enhance the accumulation of the molecule into mitochondria. Although the intracellular
distribution of HE and MitoSox red is different, their chemical reactivities in redox
reactions are quite similar.272
H 2N

H
N

NH2

R

R= -C2H5
-(CH2)6P+(Ph)3

20 HE
21 MitoSox red

Figure 11. Structure of hydroethidine and MitoSox red
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Initially, it was assumed that hydroethidine, upon exposure to superoxide anion,
formed the two-electron-oxidized product ethidium cation (E+),6 which would, in turn,
intercalate with DNA due to its charge,273 yielding red fluorescence (exicitation ~ 500 nm
and emission ~ 600 nm), and the intensity of the signal would reflect the level of
superoxide production. However, recent publications suggest that hydroethidine reacts
with superoxide anion to form a specific product, 2-hydroxyethidium (2-OH-E+). The
mass spectrometric analysis indicated that the molecular weight of the product is 16 U
greater than E+ which is consisted with 2-OH-E+ (Fig. 4).274
Detection of superoxide using hydroethidine has been executed in many
biological systems including whole cells and whole organs in live animals over the past
two decades.275 Red fluroresence derived from the reaction of hydroethidine and MitoSox
red with superoxide anion have been observed in many studies such as neurodegeneration
and neuroprotection,276 neurosignaling,277 ischemia and reperfusion,278 diabetes,279
hypertension,280 oxidative burst in leukocytes,281 vascular signaling and pathology,282
renal function and pathology,283 the anti and proapoptotic action of drugs,284 and
mitochondrial and radiation-induced damages.285 All of these studies demonstrated the
involvement of superoxide anion in many physiological and pathological conditions.
Using HE, Sorescu et al286 described the dramatic increased production of superoxide
anion in human atherosclerotic lesion, especially plaques of the shoulder.
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Figure 12. Reaction of hydroethidine and MitoSox red with superoxide anion
Many researchers found the fluorescence-based assay using hydroethidine and
MitoSox more convenient compared to the ESR technique which requires specific
training. Currently, MitoSox red is commercially available for research purposes.
In a recent review, the detection of intracellular superoxide anion through
observation of red fluorescence derived from hydroethidine and MitoSox red was
described as an unreliable approach for superoxide detection.275,287 Hydroethidine and
MitoSox red are prone to poor specificity for detecting superoxide anion because they
can be easily oxidized (via loss of the elements of a hydride anion) by other oxidants
besides superoxide anion in biological systems, and some of which yield a red
fluorescence product different from 2-OH-E+ and 2-OH-Mito-E+. Generally, the reaction
between HE and superoxide anion, generated by potassium superoxide, produces the
increased red fluorescence intensity, however, some reporters observed the decreased
fluorescence intensity in the presence of a higher concentration of superoxide anion. The
decreased fluorescence intensity could be because of the oxidation reaction between HE
and other oxidants. Earlier it was reported that HE does not readily react with hydrogen

51

peroxide.288,289 However, in the presence of metal ions such as iron or copper290 and
horseradish perxodase (HRP)291 HE is easily oxidized by hydrogen peroxide and organic
peroxide with the formation of E+ along with nonfluoresent products. Since
ferricytochrome c (cyt c3+) can react with HE with the formation ferrocytochrome c (cyt
c2+),6 complexes of iron and/or cytochromes may accelerate the reaction of HE and
peroxides in the biological systems. The same review reported the reduction of up to four
molecules of cyt c3+ by one molecule of HE to form E+ and, most likely, the dimeric
products. HPLC analysis of the products from the reaction between HE and cyt c3+
indicated the formation of E+, E+-E+ , HE-HE and HE-E+.272 Similar reaction has been
observed from MitoSox red with the mitochondrial cytochrome forming Mito-E+ and
several dimeric products.
In addition to this, HE has also been found to react with hydroxyl radical and with
H2O2 under Fenton conditions to provide the fluorescent product 2-OH-E+.291,292
However, other publication indicated the formation of HE radical cation from the
reaction of HE with hydroxyl radical by direct monitoring of pulse radiolysis.293 Some
evidences indicated the reaction of HE with NO radical, and nitrogen dioxide radical
(•NO2) yielding flurescent products.290 Other oxidants that can oxidize HE include
peroxynitrite with274 or without CO2,291 hypochlorous acids and singlet oxygen.294 Upon
irradiation with UV light, HE undergoes photooxidation in the presence of oxygen with
the formation of 2-OH-E+, which further undergoes oxidation to form E+.295
Given that the excitation light between 350 and 400 nm represent 2-OH-E+ and 2OH-Mito-E+ but not E+ or Mito- E+ , E+ can still absorb light at this wavelength and emit
fluorescence. On the other hand, since the level of detected E+ in the biological systems is
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almost 10 fold higher than that of 2-OH-E+, the fluorescence intensity could be
significantly contributed by E+.296 These drawbacks emphasize the present limitations of
using fluorescence-based detection of superoxide in intact cells or tissue. Several groups
find that high performance liquid chromatography (HPLC) is the only currently available
methodology to separate HE and its oxidation products including 2-OH-E+ thus allowing
unambiguous determination of the origin of the red fluorescence. Up until now, HPLC
based assay is the only method of choice for superoxide detection using MitoSox red.
Some drawbacks of using HPLC could be the lengthy analysis time and the optimization
of the sample extraction method.
[2] RESEARCH OBJECTIVE
The objectives of this research are to design and synthesize various novel silylated
azulenyl nitrones as spin traps for chromotropic detection of superoxide anion radical, to
study their chemical properties and to study their reaction with superoxide anion.
Towards this aim, the following nitrones were pursued.
[2.1] Silylated azulenyl nitrones:
Nitrones are known as good candidates to react with superoxide anion by spin
trapping yielding detectable diamagnetic spin adducts. A silyl substituent, a non-polar,
oxophilic, electropositive group, has a strong propensity to react with an oxygen anion
such as that which is present in a superoxide spin adduct. Hence, the presence of a nearby
silyl group in nitrone molecules is expected to confer distinctive reaction pathways with
superoxide that are not available in traditional nitrones. Moreover, because of
colorimetric properties of azulene compounds, the end products of the spin trapping
would likely yield characteristically colored molecules. Hence, the following silylated
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azulenyl nitrones 22, 23 and 24 are putatively equipped specifically for superoxide anion
detection by likely yielding characteristically colored end products with a characteristic
UV-VIS spectral profile upon reaction with superoxide anion.
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[2.2] Mitochondria-targeted silylated azulenyl nitrone:
Mitochondria are the major sites of superoxide production. To detect
mitochondrial superoxide, the chemical structure of compound 24 was modified by
incorporation of a guanylhydrazone moiety. Since guanylhydrazones are protonated at
physiological pH, the attachment of this moiety to compound 24 is expected to increase
the permeability of compound 25 into the mitochondrial membrane to reach sites of
superoxide anion generation. The structure of compound 25 is given below:
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[3] RESULT AND DISCUSSION
[3.1] Synthesis of azulenylsilane nitrones:
Nitrones have been shown to exhibit an efficient antioxidant activity in vitro and
likely in vivo by trapping reactive free radicals.223,297 Because of their spin trapping
properties, numerous nitrones have been developed for detecting superoxide anion in
biological systems in assays that require ESR spectroscopy. Superoxide adducts thereby
formed were found to be very unstable and this reduced persistence complicates their
detection by ESR. The research project described here was to synthesize silylated
azulenyl nitrones for superoxide detection that could selectively yield a characteristic
product after the oxidation reaction with superoxide anion, which could be detected by
UV-VIS and simple colorimetric techniques without using ESR spectroscopy.
[3.1.1] Synthesis of ethylated azulenylsilane mononitrone 22:
Towards our goal, the first synthetic effort in the preparation of ethylated
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azulenylsilane nitrone (22) involved four efficient steps starting from commercially
available 3-hexyne as illustrated in scheme 1. Allenylsilane (27) was prepared in one step
employing a metalation reaction according to the method reported in the literature.298
The metalation reaction was carried out by the addition of 3-hexyne to a cooled sec-BuLi
solution in THF and left for 3 hr which formed the monolithiated product. The metalation
mixture was then silylated by treatment with excess tert-butyldimethylsilylchloride at 70oC and then left overnight at room temperature (10 %). Danheiser and Becker reported
the preparation of several azulenylsilanes via cyclization reaction between allenylsilanes
and tropylium cations.299 Following the same protocol, azulenylsilane (28) was
synthesized by addition of 2.2 equiv. of tropylium tetrafluoroborate and 3.3 equiv. of
poly-4-vinylpyridine in acetonitrile (53 %) which underwent (3 + 2) annulation involving
rearrangement and cyclization. Attempted oxidation of the 1-ethyl and 3-methy group of
azulene (28) by treatment with 4 equiv. of 2,3-dichloro-5,6-dicyanobenzoquinone
(DDQ)300 failed to give the expected ketoaldehyde (29). Instead the unexpected product
ethyl aldehyde (30) in 53 % yield and the by-product alcohol (31) were obtained from
NMR data. It is obvious from the product that partial oxidation might have taken place
due to steric hindrance of the silyl group and its substituents. It was possible to optimize
the yield of ethylaldehyde (30) from 53 % to 70 % using only 2 equiv. of DDQ for
oxidation reaction. In one attempt, during the preparation of aldehyde (30),
approximately 2.5 % of bis-aldehyde (32) was also recovered. Condensation of
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Scheme 1. Synthesis of azulenylsilane ethylnitrone 2
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O

ethylaldehyde (30) with N-tert-butylhydroxylamine hydrochloride in pyridine at 45oC
ethylated azulenylsilane nitrone (22) in 47 % yield.
Synthetically, bis-aldehyde 32 was a desirable intermediate for the synthesis of
other compounds. For example, compound 32 would prove to be a useful precursor for
the preparation of other nitrones that might have significance in trapping superoxide
anion (vide infra). Keeping this in mind, efforts were made to synthesize 32 efficiently.
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[3.1.2] Synthesis of azulenylsilane carboxaldehyde nitrone:
In an attempt to synthesize mononitrone (23) from the red aldehyde 32, readily
available acetaldehyde (33) was used as the starting material. N-tert-butylimine (35) was
prepared from addition of acetaldehyde to tert-butylimine (34) at 0oC (without any
solvent) followed by distillation according to the modified method of Chancel301,302 as
illustrated in scheme 2. The N-tert-butylimine (35) was then deprotonated with LDA and
silyated by using TBDMSCl followed by repeated deprotonation with BuLi, and
methylation with iodomethane which afforded mono methylated α-silylimine (36) in a
one-pot process reported by Tietze.303 The methylated silylimine (36) is quite unstable
and was easily hydrolyzed by washing through a silica gel column using petroleum ether
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Scheme 2. Synthesis of azulenylsilane carbaldehydenitrone 23
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and ethylacetate which gave aldehyde (37). A Corey-Fuchs reaction involving the
treatment of aldehyde (37) with a mixture of triphenylphosphine and tetrabromomethane
in CH2Cl2 at 0oC provided dibromoalkene (38) via a Wittig-like reaction. Subsequently,
treatment of dibromoalkene (38) with BuLi followed by exposure to iodomethane yielded
alkynylsilane (39) via the generation of a bromoalkyne intermediate that formed in a
process consisting of dehydrohalogenation and metal-halogen exchange. A (3+2)
annulation reaction between alkyneylsilane (39) and

tropylium tetrafluoroborate in

acetonitrile in the presence of excess poly-4-vinylpyridine resulted in formation of blue
azulenylsilane (40).299 Oxidation of two methyl groups of azulenylsilane (40) with four
equivalents of DDQ300 in the presence of acetone afforded bis-aldehyde (32) which was
converted into the ethylated azulenylsilane mononitrone (23) by reaction with two
equivalents of N-tert-butylhydroxylamine hydrochloride in pyridine at 45oC.
It was presumed that the incorporation of electron withdrawing group such as the
cyano moiety in nitrone 23 might produce a stable end product generated from the spin
trapping reaction. Spin trapping of superoxide anion by nitrone 23 would produce an
unstable intermediate, containing oxygen with a negative charge at the 2- position, which
can undergo nucleophilic attack at the cyano group forming a stable six membered αpyrone ring, diagnostic for the superoxide detection, with a characteristic UV-vis spectral
profile.
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Scheme 3. Attempted synthesis of malononitrile derivative 41
However, several attempts to synthesize the malononitrile derivative 41 either by
using weak lewis acid in DMF304 or weak basic condition with malonitrile failed (scheme
3). The NMR analysis of the product indicated the absence of silyl methyl-protons and
the silyl tert-butyl protons. Failure to form the desired malononitrile derivative could be
the result of the fact that alkoxide might have attacked the silyl group which was
eventually cleaved from the azulene ring.305
After failure to synthesize compound 41, other attempts were made to incorporate
an ester group to mononitrone 23 in hopes of preparaing tricarboxylicacid triester nitrone
42 via 1,3-cycloaddition reaction. For example, compound 42 might undergo a spin
trapping reaction with superoxide anion to produce a stable six membered α-pyrone ring
system, which might have a characteristic UV-VIS spectral profile. Nitrones are well
known to undergo 1,3-dipolar cycloaddtion reaction efficiently with a variety of alkynes
to afford 4-isoxazoline.306,307 It is known that nitrones react with DMAD (dimethyl
acetylenedicarboxylate) to give 4-isoxazolines which undergo rearrangement to afford
azomethine ylides via the isomerization to acylaziridines.308 Generated azomethine ylides
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Scheme 4. Attempted synthesis of tricarboxylic acid triester derivative 42
can be trapped by a second cycloaddition with DMAD to potentially obtain compound
44.
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Scheme 5. Attempted synthesis of nitrone 45
Unfortunately, the reaction failed to give the expected product when nitrone 23
was treated with 4 equivalent of DMAD. Instead, the intermediate product 43 was
obtained, illustrated in scheme 4, which was identified by NMR data. Failure to achieve
the formation of triester 43 suggests that only one equivalent of DMAD had been
consumed in a 1,3-dipolar cycloaddition reaction to afford cyaloaddition adduct 43,
which thereafter failed to open the isoxazoline ring to rearrange to azomethine ylide
before a second cycloaddtion reaction with another equivalent of DMAD could occur.
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Another alternative could be the synthesis of nitrone 45 from nitrone 23. A
condensation reaction of nitrone 23 with hydroxylamine hydrochloride was postulated to
give oxime 46. Treatment of oxime

with trichloroacetyl isocyanate would afford

carbamoylaldoxime 45 as described by Stokker et al.309 (scheme 5). Subsequently, spin
trapping of superoxide anion with nitrone 45 would give the end product 47 which would
be formed from the intramolecular cyclization by nucleophilic substitution of the orthonegative charge of oxygen to nitrogen as shown in figure 13. The evidence of
spontaneous cyclization309 has been observed by Stokker in his effort to synthesize
carbamoylaldoxime from the compound containing a phenolic group and an oxime group
in ortho position. Instead, the only product obtained was 1,2-benzisoxazole that appeared
to be formed via spontaneous cyclization by attack of the ortho-OH group on nitrogen
without addition of any base. A similar cyclization mechanism that leads to
benzisoxazole was also suggested by Searcey.310 However, the reaction failed to give
nitrone 45. The only product formed from this reaction was dioxime 48 which was
identified by its NMR spectrum and its low resolution mass spectrum.
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Figure 13. Expected product 47 from spin trapping of superoxide anion with 45
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[3.1.3] Synthesis of azulenylsilane aminofuran nitrone:
Unsuccessful synthesis of nitrone 45 led to the development of a synthetic route
to aminofuran 49 as illustrated in the scheme 6. A one-pot approach involving the
treatment of bis-aldehyde 8 with cyclohexyl isocyanide and DMAD at 80oC in anhydrous
benzene provided aminofuran derivative 50. The reaction proceeded with the initial
formation of a zwitterionic intermediate derived from isocyanide and DMAD which is
trapped by bis-aldehyde 32.311 The condensation reaction between aminofuran derivative
50 and N-tert-butylhydroxylamine hydrochloride in pyridine at 45oC afforded
aminofuran nitrone 49.
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Scheme 6. Synthesis of aminofuran nitrone 49
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With the successful synthesis of aminofuran nitrone, an attempt was made to
improve hydrophilicity by modifying compound 49 in order to detect superoxide
generated in mitochondria. The incorporation of a guanylhydrazone moiety was sought as
a means of increasing hydrophilicity. Since a guanylhydrazone is positively charged at
physiological pH, it may traverse across cellular membranes and therefore aid in the
accumulation of nitrone into mitochondria.
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Scheme 7. Attempted synthesis of aminoguanidine hydrazone derivative 51
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In an attempt to synthesize mitochondria-targeted nitrone 51, p-formylbenzoic
acid 52 was first refluxed with triethylamine in the presence of diphenylphosphoryl azide
for 6 hr according to the protocol of the modified curtius rearrangement312 as outlined in
scheme 7 which afforded p-formylphenyl isocyanate 53 exclusively. However, treatment
of isocynate 53 with aminofuran adduct 50,313 employing Fowler’s method, failed to
give the desired urea 54 either in anhydrous benzene or in anhydrous toluene which was
planned to be transformed into nitrone 51 by treatment wih aminoguanidine
hydrochloride followed by treatment with N-tert-butylhydroxylamine hydrochloride.
[3.1.4] Synthesis of isoxazoline azulenylsilane nitrone 24:
Azulenylsilane dinitrone 55 was found to be a useful precursor for the synthesis
of other nitrones which allowed incorporation of other substituents on either the 1 or 3
position via a cycloaddition appraoch (vide infra). A simple condensation reaction
between mononitrone 23 and three equivalents of N-tert-butylhydroxylamine
hydrochloride in pyridine at 45oC yielded azulenylsilane dinitrone 55. It was also
possible to prepare this dinitrone in 33 % yield from bis-aldehyde 32 by using five
equivalent of N-tert-butylhydroxylamine hydrochloride as outlined in the scheme 8.
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Scheme 8. Synthesis of azulenysilane dinitrone 55
One of the possibilities to introduce an electron withdrawing cyano moiety to the
azulenylsilane nitrone is a 1,3-dipolar cylcoaddition approach using dinitrone 55. Coates,
who has studied the regioselective cycloaddition between and cyclic nitrones with
various alkene nitriles and alkyne nitriles, demonstrated successful formation of
cycloadducts using phenylpropiolonitrile.314 Using the same protocol, isoxazoline
nitrone, 24 was prepared regiospecifically from dinitrone 55 and phenylpropiolonitrile in
benzene at 50oC for 6 days (scheme 9).
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Scheme 9. Synthesis of isoxazoline nitrone 24

Initially, the product nitrone 24 was thought to undergo ring opening of the
isoxazoline system to produce enamine derivative 56 on basis of an the earlier study.315
But such rearrangement was not observed in this case (figure 14).
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Figure 14. Expected product 56 via ring opening

Since the expected product 56 was not observed, effort was made to open the
isoxazoline ring system. Oxidation of the nitrogen atom of a 2-substituted-4-isoxazoline
activates the system to undergo a ring opening reaction. It is reported that using an excess
amount of iodomethane improves the lability of the N-O bond thus leading to the
formation of an α,β-unsaturated ketone via an isoxazolinium salt intermediate.316,317On

69

the other hand, the presence of an easily abstractable proton at the 3-position in the
isoxazoline ring could open the ring to form the corresponding enamino derivative.318
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Scheme 10. Attempted synthesis of compound 57
Unfortunately, treatment of nitrone 24 with excess iodomethane and excess poly4-vinylpyridine did not provide the expected enamine product 57. However, three
different unexpected products were observed as shown in figure 2. Their structures are
identified as 58, 59 and 60 determined by their molar mass (MH+) 342, 497 and 271
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respectively, detected by mass spectrum. The formation of these three products suggests
the two possible processes. Hydroiodic acid that has formed under the reaction conditions
probably underwent a substitution reaction with the azulene ring to give compound 58,
and hydrolysis of the nitrone might have occurred to form aldehyde 59. Both processes
could have led to the formation of compound 60. The results are not unexpected due to
the fact that azulene, with high electron density on the five membered ring, is liable to
electophilic attack at either postions 1 or 3.319
[3.1.5] Synthesis of isoxazoline azulenylsilane guanylhydrazone nitrone (25):
Isoxazoline nitrone 24 seemed to be a promising agent for in vitro superoxide
detection. However, the drawback to this compound is that it is not a lipophilic cation
CuCN, KI
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Scheme 11. Synthesis of [3-(3-Formyl-phenylethynyl)-phenyl]-propyne nitrile 61
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which limits towards its accumulation in mitochondria. Therefore, effort has been made
to enhance its mitochondriotropic activity by incorporating a guanylhydrazone moiety.
The effort resulted in the preparation of guanylhydrazone nitrone 25 from [3-(3-Formylphenylethynyl)-phenyl]-propyne nitrile 61.
Aldehyde 61 was prepared in two steps as shown in scheme 11. According to the
method reported by Wang,320,321 cyanation

of

one

terminal

acetylene of 1,3-

diethynylbenzene 62, using two equivalents of cuprous cyanide in the presence of
TMSCl, water and a

sodium iodide at 50oC afforded nitrile

catalytic amount of

derivative 63. The crucial factor in this cyanation process was the composition of solvent.
Thus, DMSO and a co-solvent (CH3CN) should be in the ratio of 3:1. Sonogashira
coupling

of

compound

63

with

3-iodobenzaldehde322

in

THF

using

tetrakistriphenylphosphine palladium at room temperature for 24 hour provided [3-(3Formyl-phenylethynyl)-phenyl]-propyne nitrile 61. Treatment of one equivalent of nitrile
61 with dinitrone 55 in benzene at 50oC engendered 1,3-dipolar cycloaddition that
provided adduct 64. A condensation reaction between compound 64 with aminoguanidine
hydrochloride in the presence of triethylamine in pyridine at 45oC afforded
guanylhydrazone nitrone 25 (scheme 12).
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Scheme 12. Synthesis of guanylhydrazone nitrone 25
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Figure 15. Synthetic scheme of compound 65

Unfortunately, nitrone 25, despite the presence of the polar guanylhydrazone, is
found to be poorly water soluble (but could still be mitochondriotropic). Another
possibility of making mitochondria-targeted compounds involves the synthesis of salts of
nitrones 65 and 66. The presence of the aldehyde group in compound 64 is ideal for such
a purpose. Nitrone 65 could theoretically be prepared by treatment of aldehyde 64 with
Girard’s reagent as shown in figure 15. Alternatively, transformation of aldehyde 64 into
salt 66 could proceed in several steps as illustrated in figure 16. First, a reduction reaction
converts aldehyde 64 into the alcohol derivative which upon treatment with tosylchloride
would give the corresponding tosylate congener. Subsquently, SN2 reaction of the tosylate
with triphenylphosphine would afford the potential mitochondriotropic phosphonium salt
66.
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Figure 16. Synthetic scheme of compound 66

[3.2] The in vitro investigation of the reaction of novel nitrones with superoxide
radical:
After the successful synthesis and characterization of several nitrones,
experiments were conducted to test the properties and potential diagnostic application of
these novel nitrones for detecting superoxide radical anion.
[3.2.1] Attempts at in vitro detection of superoxide with ethylated azulenylsilane
mononitrone 22
The first attempt to detect superoxide involved reaction of nitrone 22 with
potassium superoxide in the presence of 18-crown-6 in benzene at room temperature323
No reaction was observed when nitrone 22 was treated with a solution of one to five
equivalents of potassium superoxide and one equivalent of crown ether dissolved in
benzene. Thus, the amounts of potassium superoxide and crown ether were increased to 5
equivalents. Still no product was observed. The result could be because of the fact that
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not enough superoxide radical anion was present because of poor solubility of potassium
superoxide. Therefore, 20 equivalents of potassium superoxide and crown ether were
directly treated with nitrone 22. These conditions gave a product in very low yield which
was impossible to identify. Finally, nitrone 22 was directly treated using 6 equivalents of
potassium superoxide. In this case, oxidation reaction was conveniently followed by TLC
by monitoring the appearance of a less polar orange product which was analyzed by 1H
NMR spectroscopy. The product was identified as aldehyde 67 by observing the
aldehyde-proton signal and the up-field shifting of the ethyl signal of the azulene ring.
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Figure 17. Formation of aldehyde end product 67
Formation of a ketone from analogous reaction between a ketonitrones and
potassium superoxide has been previously reported.323 Thus, α-diphenylene-Nphenylnitrone 68 was treated with superoxide and ketone 69 was found as a major
product as shown in figure 18. Interestingly, aldehyde 67 was found to be very unstable
because it decomposed while another orange product was started to appear as the reaction
proceeded. As a result of difficulty in purification of aldehyde 67, identification of the
second orange product was not possible. The 1H NMR data showed no aldehyde-proton,
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and a low resolution mass peak at MH+ of 663 was observed for this second orange
product. The possible explanation could be that the aldehyde product is very liable to
oxidation with superoxide anion and oxidized faster than nitrone 22 to form the second
product.
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Figure 18: Formation of ketone from α-diphenylene-N-phenylnitrone with KO2
[3.2.1.1] Mechanism of superoxide radical anion with nitrone 22
On the basis of the above result, expected aldehyde 67 was observed as an initial
orange product which is supported by the proposed mechanism of oxidation of nitrone
with superoxide (figure 19). Superoxide radical adds to nitrone 22 by radical addition to
form intermediate nitroxide anion 70. Since silicon has high affinity towards oxygen,
intramolecular nucleophilic attack of the anionic oxygen on silicon gives rise to an
unstable pentavalent intermediate324 71 which subsequently undergoes rearrangement by
migrating the azulenyl group to the adjacent oxygen as an alkoxide ion departs. Finally,
collapse of the tetrahedral intermediate provides aldehyde 67. Such an oxidative
desilylation process was initially described by Tamao and Kumada.325,326
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Information regarding the paramagnetic superoxide spin adduct, an intermediate
presumed to be formed from the reaction of nitrone 22 with superoxide anion, remained
unknown since ESR measurement was not available. However, similar to the superoxide
spin adducts of the conventional acyclic nitrones, such a superoxide spin adduct would be
expected to be highly unstable at room temperature. Grulke et al., in his ESR spin
trapping study of DMPO with metmyoglobin and hydrogen peroxide at varying
temperature, has found the nitrone peroxyl spin adduct unstable even at 0oC.327
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Figure 19. Proposed mechanism of the reaction of nitrone 22 with superoxide radical
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[3.2.2] The in vitro detection of superoxide with azulenylsilane mononitrone 23
The detection of superoxide with azulenysilane mononitrone 23 was based on the
previous method as described (vida supra). Six equivalents of potassium superoxide were
used as before. As mentioned earlier, the previous reaction was monitored by observing
an orange product on thin layer chromatography (TLC). In this case, the reaction mixture
turned completely from green to orange in 90 min. On the basis of the previous
mechanism, it was expected to obtain the bis-aldehyde 72 as an end product. However,
1

H NMR spectral information of the orange end product indicated the loss of the silyl

group, and presence of only the mono-aldehyde. The low resolution mass spectrum
detected a MH+ of 448. Unfortunately, it was not possible to purify enough for the NMR
characterization. Hence, the structure identification of end product remained unsolved. It
is believed that the superoxide spin adduct that formed was unstable and fragmented into
another compound rather than the expected one. The loss of the silyl group could result
after rearrangement via a nucleophilic attack on silicon by a second superoxide anion
since an excess of superoxide anion was used and due to the high affinity of silicon
towards oxygen.
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Figure 20. Expected product from the reaction of nitrone 23 with superoxide radical
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[3.2.3] The in vitro detection of superoxide with isoxazoline azulenylsilane nitrone 24
The unidentified end product from superoxide radical anion with nitrone 23 led
me to synthesize an analogue, the isoxazoline azulenylsilanenitrone 24, and test it for its
possible utility in superoxide detection. Using the same method as described earlier,
superoxide was solubilized in benzene by employing crown ether. The only difference in
this case was the use of three equivalents of potassium superoxide instead of six
equivalents. The green reaction mixture was completely turned into orange solution. As
in the previous case, aldehyde product 73 was expected to be formed. But surprisingly,
NMR analysis showed the absence of an aldehydic proton, and a molecular mass of 469
was detected, which did not match with the aldehyde product. A high resolution mass
spectrum of the major product was obtained and it was found to possess a molecular
formula of C29H31N3O3. With HRMS and NMR spectral analyses, the orange product was
identified as amide 74.
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74 orange

Figure 21. Structures of the expected product 73 and observed product 74 from the
reaction of superoxide radical with nitrone 24
Figure 22 shows the proposed mechanism for the formation of amide 74 from the
spin trapping of superoxide radical anion by nitrone 24. The addition of superoxide
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radical to the double bond of nitrone 24 leads to radical anion 75, which then suffers
nucleophilic attack by the negatively charged oxygen on the silicon to give an
intermediate 76 with a six-membered ring.328 Then subsequent desilylation by migrating
the azulenyl group to the adjacent oxygen atom transforms 76 into anion 77 in analogy to
the work of Tamao and Kumada.325 Rearrangement involving a nucleophilic attack of the
anionic oxygen on silicon leaves the negative charge on oxygen at the 2-position, which
in turn, undergoes a nucleophilic attack on the nitrile moiety thus resulting in the
compound 78, a six-membered ring intermediate. This step might also result in the rapid
opening of the isoxazoline ring. Meanwhile, oxygen radical may be reduced by
disproportionation (or reduced by ascorbic acid in a biological system) to form the
corresponding hydroxylamine. Dehydration

followed

by desilylation affords amide

74. In addition to amide 74, a trace of orange compound 79 was also obtained which is
identified by MS data 584 (MH+). The formation of 79 suggests a divergent mechanism
that might have taken place in the reaction. Contrary to the first mechanism, the second
mechanism pathway might have involved addition of one molecule of superoxide anion
followed by dehydration to give 79.
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Figure 22. Hypothetical mechanism of the reaction of nitrone 24 with superoxide radical
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Figure 23. Potential structure of the second product from the reaction of nitrone
with superoxide radical

24

[3.2.3.1] UV-vis and fluorescence of amide 74
The UV-vis (ultra visible) absorption spectrum and fluorescence of chromotropic
amide 74 was measured in ethanol. As shown in figure 24, the UV-vis is indicated by the
blue signal which consists of two strong absorbances in the range of 250-400 nm and one
weak absorbance in the range of 400-500 nm. The fluorescence signal, indicated by red
signal, was obtained by irradiating at the excitation wavelength 390 nm as shown in the
spectrum. The wavelength dependence of the intensity of emitted light has been recorded
at ~490 nm (emission). The quantum yield of amide was measured at 2.7 %. These
results suggest that compound 74 has fluorescence, and this probe may possibly be
employed to detect superoxide anion in biological system by identifying its orange
fluorescence. In addition to its chromotropic behavior, it may bring an advantage over
conventional cyclic nitrones which require ESR for superoxide detection.
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Figure 24. UV-vis absorbance and fluorescence of amide 74 taken in ethanol
One of the advantages of fluorescence detection is the possibility of real time
monitoring of the oxidation process.
[3.2.4] The in vitro detection of superoxide with azulenylsilane guanylhydrazone
nitrone 25
Guanylhydrazone nitrone 25 is a congener of nitrone 24. Incorporation of
guanylhydrazone moiety may make it mitochondriotropic, and thereby render it useful to
detect superoxide anion present in the mitochondria. As expected, nitrone 25 has also
shown to trap superoxide efficiently in analogy to the other aforementioned nitrones.
Using the same method as described for the other nitrones, nitrone 40 turned into
brownish orange upon reaction with potassium superoxide. The brownish orange end
product was isolated and identified as amide 80 using low resolution mass spectrum
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(MH+ = 654) which is analogous to the end product 74. In addition to amide 80, a trace of
another orange product was also observed which is identified as amide 81 (MH+ = 768)
analogous to amide 79 end product.
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80 brownish orange
Figure 25. Structure of the product amide 80 from the reaction of nitrone 25 with
superoxide radical
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Figure 26. Potential structure of the product amide 81
[3.3] The solubility study of nitrone 25 with solutol HS 15
Since nitrone 25 was poorly water soluble, its solubility in an aqueous systems
was examined using solutol HS 15 compound. Solutol HS 15 is a non-ionic solubilizer
and emulsifying agent produced from 1 mole of 12-hydroxystearic acids and 15 moles of
ethylene oxide. It provides excellent solubility to poorly soluble (lipophilic) molecules in
water, and hence, it is used for formulation of drugs in the pharmaceuticals industry.
In this experiment, as expected, solutol HS 15 was found to increase the solubility
of nitrone 25 in water. To prepare the concentration of 0.64 mg/ml of nitrone 25 in 3:7
solutol HS 15:1 % saline solution, 1 ml of solutol HS 15 was heated until it turned into a
clear liquid and cooled to room temperature. Meanwhile, 2.1 mg of nitrone 25 was
crushed to a fine powder and dissolved in 1 ml of clear solutol HS 15. It was then diluted
with 2.3 ml of 1 % saline solution in water with frequent shaking and warming. It was
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then cool to room temperature to obtained green solution. The green solution was kept in
a freezer, and found to be stable. The aqueous formulation of nitrone 25 with solutol HS
15 is believed to be amenable for mitochondrial superoxide detection and other biological
studies.
[4] CONCLUSION
Superoxide radical anion generation and its reactions in biological systems have
received considerable attention because of the involvement of superoxide in
physiological process as well as in the pathogenesis of various diseases. In biomedical
research, it is important to characterize the specific free radical and its exact role in
diseases which will allow investigators to design molecular or pharmacological
approaches to prevent or ameliorate free radical-mediated maladies. But the direct
detection of biologically generated superoxide radical anion, the identification of its sites
of production, and its quantification are of the major challenges. By their nature, the
inherent reactivity of most free radicals makes their direct in vivo detection impossible.
Because of this difficulty, various techniques based on an indirect detection of superoxide
have been developed with some degree of success.
Thus, techniques such as ESR (with cyclic nitrone spin traps), fluorescence,
chemiluminescence and cytochrome c reduction have been used to study in vitro and in
vivo detection of superoxide radicals in hopes of gaining insight with regard to cellular
metabolism and pathogenesis of diverse cytotoxic events but each exhibits potential
pitfalls as well as advantages. The fluoresence-based technique using MitoSox red is
considered as a simple and accurate method for estimation of biological superoxide, and
hence it has been widely used for this purpose. However, it was found unreliable for
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intracellular detection because it does not detect superoxide specifically.
In a search for a more reliable, selective, and convenient method, this research
developed structurally diverse novel azulenylsilane nitrones. Structurally, these novel
nitrones are set up in such a way that they are specific for superoxide detection. For
example, a nitrone moiety and an adjacent silyl group react readily with radicals and
oxygen anion respectively. Such nitrones can trap superoxide efficiently because
superoxide is both radical and an oxygen anion. Moreover, such nitrones allow
chromotropic detection of superoxide by the virtue of their azulene core. Synthesis of
dinitrone 55 has made it possible to design and synthesize other nitrone congeners with
the incorporation of the electron-withdrawing cyano group, which yields a stable,
characteristically colored, end product from its spin trapping reaction with superoxide. As
expected,

2-terbutyldimethylsilyl-1ethyl-3-azulenylnitrone

(22),

2-tert-

butyldimethylsilyl-3-azulenecarboxaldehyde1-1nitrone (23), 2-tert-butyldimethylsilyl-3tert-butylnitrone-1-(2-tert-butyl-4-cyano-5-phenyl)-azulenylisoxazoline
mitochondria-targeted
phenylethynyl)-phenyl)

(24)

and

2-tert-butyldimethylsilyl-1-[5-(3-aminoguanidinyl2-tert-butyl-4-cyano-5-phenyl

isoxazole]-3-tert-

butylazulenylnitrone (25) have been shown to trap superoxide radical anion efficiently
yielding UV-VIS identifiable and even potentially fluorescence-detectable orange
products. The in vitro results suggest that the chromotropic detection of superoxide using
these nitrones can be a promising method in contrast to other available methods. Further
work involves synthesis of mitochondria-targeted nitrones 65 and 66. Examination of
superoxide reaction with nitrone 25 in biological systems encountered is underway. The
in vivo detection of superoxide radical anion may provide additional information. Thus,
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nitrone 25 may be mitochondriotropic, and may have significant potential as a diagnostic
tool for biological superoxide detection.
[5] EXPERIMENTAL SECTION
General notes:
All of the moisture sensitive reactions have been carried out using syringe septum
rubber cap technique under N2 or Ar atmosphere or in a vial by flushing N2 or Ar gas into
it. The reactions at -78o C have been performed employing compressed CO2 and acetone
bath. All of the reactions were monitored by TLC analysis (Whatman pre-coated silica
gel F254 plates, 250 μm layer thickness), and visualization was achieved by 254 nm UV
light. The crude reaction mixtures have been purified by column chromatography using
60A (200-300 mess) on silica gel. 1H and

13

C NMR spectra were recorded on Bruker

AVANCE-400 spectrometer in deuterated chloroform. Chemical shifts were measured in
parts per million with residual solvent peak used as an internal standard. The 1H NMR
spectra were run at 400 MHz and

13

C NMR spectra were recorder at 400 MHz with

proton decoupled sequence. Coupling constants were measured in Hertz. All low
resolution mass spectra were obtained on Finnigan Navigator LC/MS instrument and
DECA LC/MS by direct injection into the mass spectrometer and detecting molecular ion
with ESI, and GC/MS. The UV-vis spectrum was recorded using a Varian Cary 50 Bio
spectrophotometer. The fluorescence (FL) spectrum was obtained using a Fluoromax-3
spectrofluorometer (Jobin Yvon/Habira). For determination of quantum yield (QY), 9,10bis(phenylethynyl)anthracene (QY=1.0) in cyclohexane was used as a fluorescence
standard.
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[5.0.1] Synthesis of 1-tert-butyldimethylsilyl-1-ethyl-3-methylallene (27)

Si

H
C

In a 150 ml three-necked round bottom flask 12.57 ml (17.6 mmol) of secbutyllithium was cooled to -30oC under argon and stirred with magnetic stirrer. To this
was added 0.723 g (8.8 mmol) of 3-hexyne via a syringe and stirred for 3 hours. The
reaction mixture was then cooled to -78oC and, 2.6 gm (17.6 mmol) of TBDMSCl in THF
was added with a syringe and left the mixture overnight. Subsequently, the reaction
mixture was poured on ice and aqueous layer was extracted with ether (3 x 20 ml). The
combined ether layers were then washed with 15 ml of saturated sodium chloride, dried
over MgSO4 and, concentrated in a rotavap. The resulting residue was distilled (b.p. 9095oC) and column chromatographed using pentane to yield 172 mg of solution colorless
oil containing allenylsilane (27). The crude solution was used to prepare compound 28
without further purification.
[5.0.2] Synthesis of 2-tert-butyldimethylsilyl-1-ethyl-3-methylazulene (28)

Si

In a 250 ml three-necked round bottom flask, fitted with an argon inlet adapter
and a magnetic stirring bar, allenylsilane (232 mg, 1.18 mmol) was treated with 10 ml of
acetonitrile, and 0.415 g of poly-4-vinylpyridine (3.94 mmol) and stirred for a minute.
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Tropylium tetrafluoroborate (0.470 g, 2.63 mmol) was then added to the resulting
suspension in one portion. The reaction mixture turned blue in one minute, which was
then stirred in the dark for 24 h at the room temperature. The dark blue reaction mixture
was filtered, and the solid residue was washed with hexane 100 ml of hexane followed by
10 ml of acetonitrile until washing were clear. The filtrate was transferred into a
separatory funnel and the top hexane layer was separated from the bottom acetonitrile
layer. The separated acetonitrile layer was further extracted from hexane (3 x 20 ml) until
the extract was clear. The combined hexane layers were then washed with 15 ml of
saturated sodium chloride, dried over anhydrous magnesium sulfate, filtered, and
evaporated in a rotavap. The blue green solid was then purified by chromatography on
silica gel (eluent hexane) to give 0.1678 g of azulenylsilane as blue-green crystals. 1H
NMR δ 8.11 (d, 1H, J = 9.4), 8.09 (d, 1H,J = 9.5), 7.39 (t, 1H, J = 9.7), 6.87 (t, 2H, J =
9.8), 3.17 (q, 2H, J = 7.5), 2.70 (s, 3H), 1.26 (t, 3H, J = 7.5), 0.91 (s, 9H), 0.5 (s, 6H); 13C
NMR δ 147.7, 140.9, 139.3, 138.1, 137.6, 134.2, 134.0, 133.4, 121.9, 121.8, 28.4, 23.0,
20.5, 19.0, 15.8, 0.00. LRMS (LC/MS-ESI, MeOH) m/e 285 (MH+)
[5.0.3] Synthesis of 2-tert-butyldimethylsilyl-1ethyl-3-azulenecarboxaldehyde (30)

O

Si

H

In a 250 ml round bottom flask, azulenyl silane (290 mg, 1.021 mmol) was
dissolved in 2ml of acetone and was added 2,3-dichloro-5,6-dicyano-1-benzoquinone
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(463.5 mg, 2.042 mmol) and stirred at room temperature for 30 minutes in the dark. The
reaction mixture immediately turned from blue to violet color. When all the reactant was
gone, 15 ml of saturated sodium thiosulfate was added and stirred for 5 min to remove
unreacted DDQ (2,3-dichloro-5,6-dicyano-1-benzoquinone). To this reaction mixture, 15
ml of sodium carbonate was added and stirred for 5 minutes to remove acidic DDQH2
(2,3-dichloro-5,6-dicyanohydroquinone). The resulting reaction mixture was then poured
into 250 ml of chloroform and transferred into separatory funnel. The separation of two
layers was hard to visualize. The bottom chloroform layer was separated from the top
aqueous layer then the aqueous layer was extracted with chloroform (2 x 25 ml). The
combined chloroform layers were washed with 15 ml of saturated sodium chloride, dried
over anhydrous magnesium sulfate, and concentrated in a rotavap. The residue violet
solid was then purified by column chromatograpghy with eluent 2:8 ethyl acetate:hexane
to provide 228 mg of azulenylsilane aldehyde (30) in 75 % yield. 1H NMR δ 10.54 (s,
1H), 9.85 (d, 1H, J = 9.85), 8.44 (d, 1H, J = 9.80), 7.79 (t, 1H, J = 9.77 ), 7.55 (t, 1H, J =
9.86), 7.47 (t, 1H, J = 9.76), 3.18 (q, 2H J = 7.54), 1.30 (t, 3H, J = 7.53), 0.97 (s, 9H) 0.56
(s, 6H);

13

C NMR δ 190.16, 153.14, 142.63, 142.42, 142.11, 140.4, 138.69, 135.74,

130.85, 130.15, 127.61, 127.49, 21.64, 18.72, 17.23, 0.00; LRMS (LC/MS-ESI, MeOH)
m/e 299 (MH+). Elution with 3:7 ethylacetate:hexane gave 32 mg of azulenysilane
alcohol-aldehyde (31) in 10 % yield. 1H NMR δ 10.52 (s, 1H), 9.92 (dd, 1H), 9.36 (dd,
1H), 7.86 (tm, 1H), 7.62 (t, 1H), 7.54(t, 1H), 5.72 (q, 1H), 1.95 (s, 1H), 1.77 (d, 3H, J =
6.64) 1.1 (s, 9H), 0.55 (s,3H) ).50 (s,3H);

13

C NMR δ 189.82, 152.25, 142.83, 141.82,

141.77, 140.76, 139.02, 138.84, 130.36, 130.18, 127.97, 67.81, 27.01, 24.29, 18.16, 0.25,
0.10; LRMS (LC/MS-ESI, MeOH) m/e 315 (MH+)
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[5.0.4] Synthesis of 2- tert-butyldimethylsilyl-1ethyl-3-azulenylnitrone (22)

Si
N
O

According to Becker et al. protocol, 101 mg (0.34 mmol) of compound 30 was
treated with N-tert-butyl hydroxylamine (212.84 mg, 1.69 mmol) and anhydrous
magnesium sulfate (204 mg, 1.69 mmol) in 2 ml of anhydrous pyridine under argon. The
reaction mixture was stirred at 40oC for 21 days. The TLC showed the product as well as
some starting material. The reaction mixture was then poured into 20 ml of water and
extracted with ether (3 x 25 ml). The ether layer was washed with 10 ml of saturated
sodium chloride, dried over magnesium sulfate and concentrated in a rotavap. The
residue

product

was

then

purified

by

column

chromatography

using

7:3

ethylacetate:hexane to provide 58.6 m of nitrone (22) in 47 % yield. 1H NMR δ 8.25 (d,
2H J = 9.75), 8.11 (s, 1H), 7.60 (t, 1H), 7.22 (t, 1H), 7.18 (t, 1H), 3.16 (q, 2H), 1.7 (s,
9H), 1.26 (t, 3H), 0.94 (s, 9H), 0.49(s, 6H); 13C NMR δ 146.71, 141.68, 140.04, 138.54,
137.88, 135.03, 133.63, 129.53, 124.12, 123.93, 123.31, 69.81, 28.46, 26.87, 21.65,
18.77, 17.43, -1.56; LRMS (LC/MS-ESI, MeOH) m/e 369 (MH+)
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[5.0.5] Synthesis of acetaldehyde tert-butylimine (35)

N

H

Following Tieze’s method, I placed 16.5 g of tert-butylamine (226 mmol) in a
three-necked round bottom flask, fitted with a dropping funnel and a magnetic stir bar,
(under argon and kept on ice bath). Ten 10 g of acetaldehyde (226 mmol) was introduced
dropwise at 0oC into the flask. The mixture was stirred at this temperature for 3 hr, then
600 mg of solid KOH (10.7 mmol) was added and kept in a refrigerator at 4oC for 12 hr
to allow two layers to seperate. The bottom aqueous layer was removed using a
separatory funnel and the top organic layer was transferred into a flask which was then
distilled (bp 66-70oC) to provide 19.9 g of aldiimine (35) in 88% yield as a colorless oil.
The product was found identical to an authentic sample by using 1H NMR. 1H NMR δ
7.61 (q, 1H J = 4.8 Hz), 1.90 (dd, 3H, J = 4.8 Hz), 1.10 (s, 9H)
[5.0.6] Synthesis of 2-tert-butyldimethylsilyl-propylimine (36)
t

N Bu

H
Si

Following the procedure of Tietze’s,303 13.4 ml of 1.5 M LDA in THF (20.20
mmol) was treated with 2 g of acetaldehyde aldimine 35 in THF (20.20mmol) at 0oC and
the reaction mixture was stirred at this temperature for 30 min under argon. Initially the
reaction mixture turned into yellow, and later it turned into red. To this mixture, 3.05 g of
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TBDMSCl in THF (20.20 mmol) was added followed by the addition 0.373 g of Bu4NI
(1.01 mmol) at 0oC. The reaction mixture was then stirred at room temperature for 3 hr.
The resulting yellow color solution was then treated with 8.08 ml of BuLi in hexane
(20.20 mmol) at 0oC and stirred for 1 hr at this temperature. Subsequently, 2.86 g of
iodomethane (20.20 mmol) was added at this temperature and then allow the mixture to
warm up to room temperature over 12 hr. The reaction mixture was then diluted with 40
ml of diethyl ether and poured onto ice-water. The organic layer was separated and the
aqueous layer was extracted with diethyl ether (2 x 40 ml). The combined organic layers
were washed with saturated NaCl, dried over MgSO4 and concentrated in a vacuo to
provide 6.5 g of crude 36 which has been used to prepare compound 37 without further
purification.
[5.0.7] Synthesis of 2-tert-butyldimethylsilyl-propylaldehyde (37)
O

H
Si

The crude product 36 was hydrolysed by dissolving in 2 ml of petroleum
ether/EtOAc (7:1) and filtered through a column of silica gel using petroleum
ether/EtOAc (7:1) as eluent to furnish 2.82 g of silylaldehyde (81 %) as an orange oil.
The product is identical to the authentic sample. 1H NMR δ 9.72 (d, 1H, J = 1.6), 2.49
(dq, 1H J = 6.7, 1.6), 1.16(d, 3H, J = 6.7), 0.92 (s, 9H), 0.03 (s, 3H), 0.01(s, 3H);
NMR δ 203.22, 40.95, 26.69, 17.50, 8.95, -6.71, -6.88; LRMS (GC-MS) m/e 172 (M+)
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13

C

[5.0.8] Synthesis of 1-dibromo-3-tert-butyldimethylsilyl-1-butene (38)
Br

Br

H
Si

2.7 g of tetrabromomethane (8.14 mmol) was stirred in CH2Cl2 (1M) and kept at
0oC. To this solution was added 4.35 g triphenylphosphine (16.6 mmol) in CH2Cl2 (2M)
and stirred at this temperature for 30 min. Then the solution of 500 mg of aldehyde 37
(2.90 mmol) in CH2Cl2 (0.5M) was added and stirred at 0oC for 2 hr. The reaction
mixture was then treated with 42 ml of ether and the resulting white precipitates were
filtered off. The filtrate was then washed with 9 ml of H2O, 9 ml of saturated NaHCO3, 9
ml of saturated NH4Cl, 9 ml of saturated NaCl, and dried over MgSO4. The solvent was
then evaporated in vacuo and the residue was eluted with 30:1 petroleum
ether:ethylacetate in a column chromatography to furnish 733 mg of dibromo compound
38 in 77 % yield as a colorless oil. 1H NMR δ 6.25 (d, 1H, J = 11.5), 2.08 (dq, 1H, J =
11.5, 7.2), 1.10 (d, 3H, J = 7.2), 0.94 (s, 9H), 0.00 (s, 3H), -0.01(s,3H);

13

C NMR δ

142.82, 84.41, 27.04, 26.52, 17.37, 14.79, -7.28, -7.34; LRMS (GC-MS) m/e 328 (M+)
[5.0.9] Synthesis of 4-tert-butyldimethylsilyl-1-pentyne (39)

Si

340 mg of 38 (1.07 mmol) was dissolved in THF (0.25M) and kept in dry ice/
acetone water bath. To this solution 1 ml of BuLi ( 2.28 mmol) was added at -78oC under
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argon and stirred for 30 min. The reaction mixture was then quenched with 0.08 ml (182
mg) of iodomethane (1.28 mmol) and heated at 40oC for 2 hr. After 2 hr stirring, the
reaction mixture was brought to room temperature and stirred for another 18 hr. To this
reaction mixture 10 ml of 1:1 ether/water was added and then aqueous layer was
separated and washed with ether (3x 20 ml). The organic layers were combined and
washed with 20 ml of saturated NaCl, drie over MgSO4 and concentrated in rota vap. The
residue was then purified by column chromatography using petroleum ether to furnish
160 mg of 39 as pale yellow oil (82 %). 1H NMR δ 1.78 (s, 3 H), 1.75-1.79 (m, 1 H), 1.17
(d, 3 H, J = 7.2), 0.95 (s, 9 H), -0.02( s, 3H), 0.04 (s, 3H);

13

C NMR δ

83.20, 74.89,

27.12, 17.40, 16.29, 10.29, 3.61, -7.42, -7.82; LSMS (GC-MS) m/e 182 (M+)
[5.1.0] Synthesis of 2-tert-butyldimethylsilyl-1,3-dimethylazulene (40)

Si

In a three necked round bottomed flask, containing a magnet stirrer, 2.13 mg of
38 (11.69 mmol) was treated with 85 ml of acetonitrile and 4.06 g of poly(4vinylpyridine (38.57 mmol) and stirred under argon at room temperature. To the resulting
suspension was added 4.58 g of tropylium tetrafluoroborate (25.72 mmol) in one portion.
The reaction mixture was turned into blue in 60 seconds and stirred at room temperature
in the dark for 24 h. The dark blue reaction mixture was then filtered, and the solid
residue was washed with 300 ml of hexane and 20 ml of acetonitrile until the washing
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became clear. The filtrate was transferred into a separatory funnel, shaken vigorously,
and the top blue hexane layer was separated from the bottom brown acetonitrile layer.
The acetonitrile layer was extracted with hexane (4 x 40 ml). The combined hexane
layers were washed with 15 ml of saturated sodium chloride, dried over anhydrous
MgSO4, filtered, and evaporated the solvent to obtain blue-green solid. The blue green
residue was then purified by column chromatography using hexane to furnish 687 mg of
azulene 40 as blue-green crystals in 22% yield. 1H NMR δ 8.18 (d, 2H, J = 9.8), 7.46 (t,
1H, J = 9.8), 6.96 (t, 2H, J = 9.8), 2.81 ( s, 6H), 1.05 ( s, 9H), 0.6 (s, 6H);

13

C NMR δ

147.12, 137.87, 136.89, 132.68, 132.28, 120.38, 26.99, 19.33, 14.38, - 1.46; LRMS
(LC/MS-ESI, MeOH) m/e 271 (MH+)
[5.1.1] Synthesis of 2-tert-butyldimethylsilyl-1,3-azulenedicarboxaldehyde (32)

O

H

Si

O

H

90 mg of 40 (0.33 mmol) was dissolved in 5 ml of acetone at room temperature.
To this solution was added 359 mg of DDQ (2,3-dichloro-5,6-dicyano-1,4-benzoquinone)
(1.58 mmol) in one portion. The reaction mixture immediately turned color from blue to
red as it was stirred in the dark for 1 hour. When all reactant was gone the reaction
mixture was stirred with 15 ml of saturated sodium thiosulfate solution to remove
unreacted DDQ for 2 min and then 15 ml of saturated sodium bicarbonate was added, and
then it was stirred for 2 min to remove acidic DDQH2 (2,3-dichloro-5,6-
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dicyanohydroquinone). The reaction mixture was then extracted with chloroform (5 x 40
ml). The combined bottom red organic phases were subsequently washed with 15 ml of
saturated NaCl solution, dried over anhydrous MgSO4, filtered and evaporated. The red
residue was then purified by column chromatography using 7:3 hexane:ethylacetate to
provide 88.4 mg of bis-aldehyde 32 in 89 % yield as red crystals. 1H NMR δ 10.59 (s,
2H), 10.12 (dd, 2H, J = 10), 8.11 (tt, 1H, J = 10), 7.94 ( t, 1H, J = 10), 1.05 ( s, 9H), 0.61
( s, 6H); 13C NMR δ 190.28, 162.4, 144.9, 142.75, 140.94, 134.14, 132.73, 27.06, 17.99,
0.98; LRMS (LC/MS-ESI, MeOH) m/e 299 (MH+)
[5.1.2] Synthesis of 2-tert-butyldimethylsilyl-3-formyl-azulene-1-nitrone (23)

O

H

Si

N
O

To the mixture of 50 mg of bis-aldehyde 32 (0.167 mmol), 42.2 mg of tertbutylhydroxylamine hydrochloride (0.335 mmol) and 40.4 mg of anhydrous magnesium
sulfate (0.335 mmol) was added 1.4 ml of pyridine to dissolve. The reaction mixture was
then stirred and heated to 40oC for 1 week under argon. The color of the reaction solution
changed from red into green. The crude product was then poured into 5 ml of water and
extracted with 5 ml of ether. Then aqueous layer was separated from ether layer. The
aqueous layer was further extracted with ether (2 x 5 ml). The combined ether layer was
washed with saturated sodium chloride, dried over magnesium sulfate, filtered and,
evaporated in a vacuo. The residue was then purified by silica gel column
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chromatography using 5:5 hexane:ethylacetate to produce 20.3 mg of mononitrone 23 in
33 % yield as green crystals. 1H NMR δ 10.51 (s, 1H), 9.95 (d, 1H, J = 9.9), 8.27 (d, 1H,
J = 9.9), 8.10 ( s,1H), 7.94 (t, 1H, J = 9.9), 7.74 (t, 1H, J = 9.9), 7.69 (t, 1H, J = 9.9), 1.71
(s, 9H), 0.99 (s, 9H), 0.53 (s, 6H); 13C NMR δ 189.25, 156.37, 143.34, 140.97, 140.49,
139.84, 139.52, 132.35, 131.69, 129.2, 128.19, 127.83, 70.46, 28.35, 26.81, 18.35, -0.65;
LRMS (LC/MS-ESI, MeOH) m/e 370 (MH+)
[5.1.3] Synthesis of 2-tert-butyldimethylsilyl-1,3-azulenyldinitrone (55)

Si

N

N

O

O

A solution of 77 mg of dialdehyde 32 (0.26 mmol), 162 mg of tertbutylhydroxylamine hydrochloride (1.3 mmol), 155 mg of anhydrous magnesium sulfate,
and 1 ml of pyridine was stirred at 45oC for 2 weeks under argon. The resulting mixture
was then pour into 5 ml of water and extracted with 5 ml of ether. The aqueous layer was
extracted with (2 x 5 ml) ether. The combined ether layers were washed with saturated
sodium chloride, dried over MgSO4, filtered and concentrated in vacuo. The resulting
residue was then purified by column chromatography using 100:1 chloroform:methanol
as eluenting solvent to furnish 35.4 mg of 55 in 31 % yield as green crystals. Compound
55 was also prepared in 35 % yield by heating 66 mg of mononitrone 23 (0.18 mmol),
67.4 mg of tert-butylhydroxylamine hydrochloride (0.54 mmol), 64.6 mg of anhydrous
MgSO4 (0.54 mmol) and 1 ml of pyridine at 45oC for 10 days. 1H NMR δ 8.35 (d, 2H, J =
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9.5), 8.07 (s, 2H), 7.76 (t, 1H, J = 9.7), 7.48( t, 2H, J = 9.9), 1.70 (s,18H), 0.95 (s, 9H),
0.48 (s, 6H); 13C NMR δ 149.62, 139.58, 138.71, 138.04 128.74, 126.86, 126.11, 70.08,
28.44, 26.53, 18.70, -2.05; LRMS (LC/MS-ESI, MeOH) m/e 441 (MH+)
[5.1.4]

Synthesis

of

2-[2-(tert-butyldimethyl-silanyl)-3-formyl-azulen-1-yl]-5-

cyclohexylamino-furan-3,4-dicarboxylic acid dimethyl ester (50)

MeO 2C
O

H

CO2Me

Si

O

NH

A mixture of 250 mg of bis-dialdehyde 32 (0.84 mmol) and 92 mg of DMAD
(dimethyl acetylenedicarboxylate) (0.84 mmol) was dissolved in 8.5 ml of anhydrous
benzene and heated at 80oC under argon. To the solution was added 119 mg of
cyclohexylisocyanide (0.84 mmol) by syringe, and the heating was continued at 80oC for
further 5 days. The color of the reaction changed from red into brown. The solvent was
then evaporated in a vacuo, and the crude residue was purified on column
chromatography using 8:2 hexane:ethylacetate to obtaine first starting material, and then
polarity was increased to 7:3 hexane:ethylacetate to furnish 117 mg of 50 as wine red
solid in 25 % yield. 1H NMR δ 10.59 (s, 1H), 9.99 (dd, 1H, J = 9.9, 0.8), 8.40 (dd, 1H, J =
9.9, 0.8), 7.90 (t, 1H, J = 9.8), 7.71 (t, 1H, J = 9.8), 7.40 (t, 1H, J = 9.7), 6.72 (d, 1H, J =
8.9), 3.82 (s, 3H), 3.52-3.365 (m, 1H), 3.49 (s, 3H), 1.20-2.05 (m, 10H), 0.95 (s, 9H),0.34
(s, 3H), 0.23 (s, 3H);
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C NMR δ 189.84, 165.34, 164.39, 162.04, 157.31, 146.20,

141.70, 141.15, 139.83, 139.73, 138.19, 131.24, 130.20, 129.45, 125.96, 118.56, 86.09,
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51.74, 51.35, 51.03, 34.01, 33.89, 27.34, 25.27, 24.69, 24.60, 17.95, -1.86, -3.42; LRMS
(LC/MS-ESI, MeOH) m/e 550 (MH+)
[5.1.5] Synthesis of 2-[2-(tert-butyldimethyl-silanyl)-3-tert-butylnitrone-azulen-1-yl]5-cyclohexylamino-furan-3,4-dicarboxylic acid dimethyl ester (49)

MeO 2C

CO2Me

Si

N

O

N
H

O

A solution of 13.5 mg of aminofuran adduct 50 (0.025 mmol), 9.3 mg of tertbutylhydroxylamine hydrochloride (0.074 mmol), 8.9 mg of magnesium sulfate (0.074
mmol), and 0.3 ml of pyridine was purged with argon and stirred at 50oC for 7 days. The
reaction mixture was then poured into 5 ml of water and extracted with ether (3 x 5 ml).
The combined ether layers were then washed with 10 ml of saturated sodium chloride,
dried over anhydrous magnesium sulfate, filtered, and evaporated in a vacuo. The
resulting green residue was then purified by column chromatography using 5:5
ethylaetate/hexane to produce 3 mg of nitrone 49 in 20 % yield. 1H NMR δ 8.48 (d, 1H, d
= 9.9), 8.25 (d, 1H, d = 9.2), 8.2 (s, 1H), 7.74 (t, 1H, d = 9.8), 7.44 (t, 1H, d = 9.9), 7.37 (
t, 1H, d = 9.8), 6.68 (d, 1H, d = 8.8), 3.81 (s, 3H), 3.50 - 3.57 (m, 1H), 3.49 (s, 3H), 1.85
– 2.00 ( m, 2 H), 1.7 ( s, 9H), 1.10 – 1.40 ( m, 8H), 0.28 ( s, 3H), 0..2 ( s, 3H); 13C NMR
δ 165.47, 164.61, 161.99, 151.19, 144.02, 140.27, 139.60, 139.55, 136.68, 136.10,
129.02, 126.50, 125.40, 125.33, 125.22, 118.07, 86.11, 70.15, 51.11, 51.37, 51.00, 33.97,
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28.47, 27.17, 25.36, 24.79, 24.63, 18.48, 0.00, -3.20, -4.15 ; LRMS (LC/MS-ESI, MeOH)
m/e 621 (MH+)
[5.1.6] Synthesis of p-formylphenyl isocyanate (53)
O
N

C

O

According to the modified method of Yamada, 1 gm of 4-carboxybenxzaldehyde
(6.67 mmol) was suspended in 16 ml of anhydrous methylene chloride and added 0.9 ml
(0.66 g) of triethylamine (6.67 mmol). After all the solid had dissolved, 1.44 ml of
diphenylphosphoryl azide (6.67 mmol) was added dropwise through a syringe. The
content was then refluxed for 6 hr. The reaction mixture changed the color from colorless
to pale yellow. The solvent was then evaporated in a vacuo. The resulting yellow solid
was then dissolved in 40 ml of ether and washed with aqueous sodium bicarbonate at PH
9 (2 x 25 ml). The ether layer was dried over anhydrous magnesium sulfate, filtered, and
evaporated ether to provide 1 gm of 53 as a pale yellow solid in 100 % yield. 1H NMR δ
10.12 (s, 1H), 8.20 (d, 2H, J = 8.3), 7.80 (d, 2H, J = 8.3);

13

C NMR δ 191.33, 171.73,

140.03, 135.34, 130.05, 129.70; LRMS (GC-MS, CH2Cl2) m/e 147 (M+), 146, 118, 90,
63, 51; IR (NaCl) 2136 cm-1 for isocyanate group.
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[5.1.7] Synthesis of 2-tert-butyl-3-[2-(tert-butyldimethyl-silanyl)-3-nitrone-azulen1-yl]-5-phenyl-2,3-dihydro-isoxazole-4-carbonitrile (24)

NC
Si
O
N

N

O

The mixture of 26 mg of dinitrone 55 (0.06 mmol) and 7.5 mg of
phenylpropiolonitrile (0.06 mmol) was dissolved in 1 ml of anhydrous benzene and
heated at 50oC for 6 days. The solvent was then dried in a vacuo to provide green solid.
The resulting green residue was then purified by column chromatography on silica gel
using 7:3 hexane:ethylacetate which afforded 25 mg of 24 as green crystals in 75 %
yield and 19 % of starting materials. 1H NMR δ 9.22 (d, 1H, J = 9.5), 8.21 (d, 1H, J =
9.5), 8.19 ( s, 1H), 7.92 (dd, 2H, J = 8, 1.3), 7.65 (t, 1H, J = 9.7), 7.47 (m, 3H), 7.32 (t,
1H, J = 9.7), 7.25 (t, 1H, J = 9.7), 6.33 (s, 1H), 1.70 ( s, 9H), 1.25 (s, 9H), 1.00 (s, 9H),
0.73 (s, 3H), 0.40 (s, 3H); 13C NMR δ 161.62, 146.75, 140.63, 139.34, 138.55, 137.21,
136.95, 135.44, 131.68, 129.30, 128.86, 127.12, 125.87, 125.66, 124.90, 124.63,
116.20, 85.80, 70.06, 65.28, 61.87, 28.38, 28.03, 25.39, 19.18, 0.27, -1.26; LRMS
(LC/MS-ESI, MeOH) m/e 568 (MH+)
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[5.1.8] Synthesis of (3-ethynyl-phenyl)-1-propyne nitrile (63)

CN

Three-necked round bottom flask, fitted with argon inlet and

containing a

magnetic stirring bar, is charged with 11.3 ml of DMSO, (dimethyl sulfoxide), 3.75 ml of
acetonitrile and 0.2 ml of water, and stirred the solution rapidly. To the rapidly stirring
solution, 1.35 g of cuprous cyanide (15 mmol) was added very slowly to avoid formation
of lumps. Then 113 mg of sodium iodide (0.752 mmol) was added to the reaction
mixture, and was stirred for 1 min. Then 1 ml (0.940 g) of 1,3-diethynylbenzene (7.53
mmol) was added slowly via syringe. Subsequently, 2.9 ml (2.45 g) of
chlorotrimethylsilane (22.56 mmol) was added dropwise via syringe over 20 min and
stirred the reaction mixture at 50oC for 24 hr. The reaction mixture was then cooled to
room temperature and then 5 ml of water was added. It was then extracted with ether (5 x
10 ml). The combined ether layers were then washed with 25 ml of saturated sodium
bicarbonate, 25 ml of saturated sodium chloride, dried over anhydrous magnesium
sulfate, filtered and evaporated the solvent by rotatory evaporation to give crude yellow
oil. The crude residue was then purified by silica gel column chromatography using
pentane as eluenting solvent to afford 147 mg of (3-ethynyl-phenyl)-1-propyne nitrile as
white crystals in 13 % yield. 1H NMR δ 7.72 (sm, 1H), 7.63 (dt, 1H, J = 0.02), 7.58 (dt,
1H, J = 0.02), 7.39 (t, 1H, J = 0.02), 3.16 (s, 1H);
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C NMR δ 136.74, 135.26, 133.39,

129.03, 123.44, 118.06, 105.19, 81.67, 81.49, 79.26, 63.59; LRMS (GC/MS, CH2Cl2) m/e
151 (M+)
[5.1.9] Synthesis of [3-(3-formyl-phenylethynyl)-phenyl]-propyne nitrile (61)
O

H

NC

The mixture of 87 mg of (3-ethynyl-phenyl)-1-propyne nitrile 63 (0.576 mmol),
120.3 mg of 3- iodobenzaldehyde, and 0.8 ml triethylamine (58.5 mg, 0.576 mmol) were
dissolved in 1.5 ml of anhydrous THF, and the solution was deoxygenated by purging
argon in it. Then 22 mg of tetrakistriphenylphosphine palladium (0.019 mmol) was added
to the solution, and the reaction was allowed to stir for 20 min at room temperature. After
20 min, 0.9 mg of cuprous iodide (4.5 x 10

-3

mmol) was added to the stirring solution

and stirred at room temperature for 2 hr, followed by heating further at 50oC for 2 hr.
The solvent was then evaporated in a rotatory evaporation to give brown solid. The
residue was then purified by silica gel column chromatography using 1:9
dichloromethane:hexane to collect starting material. The polarity was increased to 2:8
dichloromethane:hexane to afford 80 mg of 61 as a golden solid in 55 % yield. 1H NMR
δ 10.2 (s, 1H), 8.04 (sm,1H), 7.89 (dm, 1H, J = 7.7), 7.78 (m, 2H), 7.69 (dm, 1H, 7.8),
7.60 (dm, 1H, J = 7.8), 7.56 (t, 1H, J = 7.7), 7.44 (t, 1H, J = 7.8);
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C NMR δ 191.30,

137.13, 136.59, 136.27, 134.81, 133.21, 132.90, 129.61, 129.26, 123.99, 123.69, 118.16,
105.22, 89.72, 88.64, 81.77, 63.62; LRMS (GC/MS, CH2Cl2) m/e 255 (M+)
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[5.2.0] Synthesis of 2-tert-butyl-3-[2-(tert-butyldimethyl-silanyl)-3-nitrone-azulen-1yl]-5-[3-(3-formyl-phenylethynyl)-phenyl]-2,3-dihydro-isoxazole-4-carbonitrile (64)
CHO

NC
Si

N

O
N

O

A mixture of 288 mg of dinitrone 55 (0.65 mmol) and 17.4 mg of [3-(3-Formylphenylethynyl)-phenyl]-propyne nitrile 63 (0.65 mmol) was dissolved in 8 ml of
anhydrous benzene. The reaction mixture was then heated at 50oC for 1 week. The
solvent was then dried in a vacuo to afford a green solid which was purified by column
chromatography on silica gel .The column was washed with 7:3 hexane:ethylacetate to
elute 380 mg of aldehyde 64 as green crystals in 84 % yield with 16 % of starting
materials 55. 1H NMR δ 10.02 (s, 1H), 9.23 (d, 1H, J = 9.8), 8.21 (d, 1H, J = 10.1), 8.19,
(s, 1H), 8.06 (s, 1H,),8.04 (s, 1H), 7.94 (dm, 1H, J = 8.1), 7.87 (dm, 1H, J = 7.7), 7.80
(dm, 1H, J = 7.7), 7.68 (m, 2H), 7.54 (t, 1H, J = 7.7), 7.47 (t, 1H, J = 7.8), 7.34 (t, 1H, J =
9.8), 7.28 (t, 1H, J = 10.1), 6.36 (s, 1H), 1.71 (s, 9H), 1.27 (s, 9H), 1.00 (s, 9H); 13C NMR
δ 191.43, 160.59, 146.86, 140.65, 139.46, 138.62, 137.19, 137.17, 137.02, 136.57,
135.05, 134.61, 133.13, 130.03, 129.37, 129.25, 129.20, 129.12, 127.20, 126.33, 125.72,
124.98, 124.77, 124.02, 123.70, 115.89, 89.64, 89.19, 86.61, 70.12, 65.39, 61.96, 28.39,
28.03, 25.43, 19.20, 0.27, -1.25; LRMS (LC/MS-ESI, MeOH) m/e 696 (MH+)
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[5.2.1] Synthesis of 2-tert-butyl-3-[2-(tert-butyldimethyl-silanyl)-3-nitrone-azulen-1yl]-5-[3-(3-guanylhydrazone-phenylethynyl)-phenyl]-2,3-dihydro-isoxazole-4carbonitrile (25)
H
N

H

N

N
H
N
H

NC
Si

N

O
N

O

A mixture of 554 mg of 64 (0.797 mmol), 88.2 mg of aminoguanidine
hydrochloride (0.797 mmol) and 0.33 ml of triethylamine (2.39 mmol) was dissolved in
1.5 ml of pyridine. The reaction mixture was then stirred for 7 days at 45oC. The resulting
green reaction solution was then treated with 5 ml of water and extracted with
dichloromethane (6 x 10 ml). The combined organic phases were then washed with 10 ml
of saturated sodium chloride, dried over anhydrous magnesium sulfate, filtered, and
evaporated in a vacuo to obtain green solid. The green residue was then purified by
column chromatography on silica gel. The column was first washed with 60:40
hexane:ethylacetate to collect 10 mg of starting material 64. The polarity of solvent was
then increased to 95:5 chloroform:methanol to wash the column to afford 570 mg of
nitrone 25 in 95 % yield as a green crystal. 1H NMR δ 9.43 (d, 1H, J = 9.88), 8.33 (s,
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1H), 8.01 (s, 1H), 8.00 (d, 1H, J = 9.50), 7.90 (s, 1H), 7.70-7.80 (m, 4H), 7.39 (d, 1H, J =
7.80) 7.58 (d, 1H, J = 8.29), 7.20-7.44 (m, 5H), 6.30 (s, 1H), 1.7 (s, 9H), 1.25 (s, 9H),
1.04 (s, 9H), 0.7 (s, 3H), 0.5 (s, 3H); 13C NMR δ 160.71, 155.80, 147.18, 146.03, 140.26,
140.10, 137.81, 137.75, 136.79, 134.90, 134.26, 133.40, 132.76, 131.74, 130.58, 130.17,
128.97, 128.75, 127.63, 126.47, 126.22, 125.87, 125.39, 124.06, 123.79, 123.02, 116.18,
90.66, 88.85, 86.22, 70.20, 65.40, 61.77, 28.26, 28.01, 25.36, 19.17, -0.08, -1.17; LRMS
(LC/MS-ESI, MeOH) m/e 752 (MH+)
[5.2.2] Synthesis of 2-tert-butyldimethylsilyl-1,3-azulenyldioxime (48)

Si
HO
N

OH
N

In an attempt to synthesize nitrone oxime 46, 13 mg of mononitrone 23 (0.0352
mmol) was mixed with 2.5 mg of hydroxylamine hydrochloride (0.0352 mmol) and
dissolved in 1 ml of pyridine in a small vial under argon. The reaction mixture was
heated at 40oC. After 2 hr of stirring no product has been observed by TLC so 1 more
equivalent of hydroxylamine hydrochloride was added and stirred the reaction mixture
for further 24 hr. When TLC showed no more reactant, 8 ml of water was added to the
resulting reaction mixture and extracted with ethylacetate (3 x 10 ml). The combined
organic layer was washed with 10 ml saturated sodium chloride solution, dried over
anhydrous magnesium sulfate, filtered and concentrated in a vacuo. Purification of the
resulting green solid by column chromatography on silica gel using 7:3 hexane:
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ethylacetate failed to provide nitrone oxime 46 indicated by NMR and LRMS. Instead 10
mg of dioxime 48 as green crystals in 87 % yield was obtained confirmed by NMR and
LRMS. 1H NMR δ 9.22 (d, 2H, J = 9.6), 8.80 (s, 2H), 7.70 (t, 1H, J = 9.8), 7.5 (br s, 2H),
7.39 (t, 1H, J = 10) 0.99 (s, 9H), 0.52 (s, 6H);
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C NMR δ 150.80, 150.05, 140.67,

139.87, 138.51, 127.38, 127.08, 26.98, 18.46, -0.74; LRMS (LC/MS-ESI, MeOH) m/e
329 (MH+)
[5.2.3]

Attempted

synthesis

of

2-tert-butyldimethylsilyl-3-nitrone-1-

azulenemalonolitrile (41)
A mixture of 15 mg of mononitrone 23 (0.041 mmol) and 2.7 mg of malononitrile
(0.041 mmol) in 0.5 ml of dimethylformamide (DMF) was treated with 1.7 mg of LiCl
(0.0041 mmol) and stirred either at room temperature for 24 hour. Thin layer
chromatography showed one reactant spot and another orange spot. The reaction mixture
was then treated with 2 ml of water and extracted with 5 ml ethylacetate several times.
The combined ethylacetate layers were dried over magnesium sulfate and concentrated in
vacuo. The resulting residue was purified by column chromatography. The column was
washed first with 5:5 ethylacetate/ hexane to collect 3.6 mg of starting material then
polarity was increased to 80 % to collect 7.3 mg of an orange product. An unidentified
orange product has been observed by 1H NMR that contained no tert-butyl and methyl
groups attached to silyl group. The compound has not been identified yet.
[5.2.4] Attempted synthesis of isoxazole tricarboxylic acid trimethylester (44)
A mixture of 10 mg of mononitrone 23 (0.0271 mmol) and 13.3 μl dimethyl
acetylenedicarboxylate (0.108 mmol, 4 equiv.) was dissolved in 0.2 ml of
dichloromethane. The reaction mixture was stirred at room temperature for 11 hr.
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Evaporation followed by purification on column chromatography using 7:3
hexane:ethylacetate gave 5 mg of purple product. However, the purple compound is
identified as an intermediate 43 based on 1H NMR and MS. Therefore, the reaction is
further stirred for 7 days at 35oC but only the intermediate compound was recovered.
[5.2.5] Attempted synthesis of 54 from p-formyl isocyanate and aminofuran adduct
(50)
Following the modified method of Fowler,313 treatment of 3.4 mg of p-formyl
isocyanate 53 (0.022 mmol) with 12 mg of aminofuran adduct 50 (0.022 mmol) dissolved
either 0.2 ml of benzene or toluene and heated at 90oC for 7 days failed to show any
product by TLC. The solvent was then removed by rotator evaporation. Recrystallized
from ether gave 12 mg of wine red solid (89 %) which is identical to the starting material
50 confirmed by TLC and 1H NMR.
[5.2.6] Attempted synthesis of α,β–unsaturated ketone derivative of isoxazoline (57)
A mixture of 7.2 mg of carboxynitrile compound 24 (0.0127 mmol), 0.04 ml of
iodomethane (0.609 mmol) and 64 mg of poly-4 vilylpyridine (0.609 mmol) was
dissolved in 0.5 ml of tetrahydrofuran. The reaction was stirred 40oC for 36 hour. After
three product were observed by TLC, the reaction mixture was filtered and washed with
15 ml of hexane:ethylacetate and concentrated in a vacuo. The resulting residue was then
chromatographed on silica gel by washing the column with 8:2 hexane:ethylacetate to
collect the first two purple products 1.5 mg and 3 mg respectively and then polarity was
increased to 5:5 ethylacetate:hexane to collect 1 gm of green product and 0.8 mg of
starting material. However, the mixture of products failed to indicate the presence of 57
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by 1H NMR and LRMS. Three products were presumed to be 58, 59 and 60 based on
their LRMS data.
[5.2.7] Aldehyde product (67) of superoxide trapping with nitrone 22

Si
O

O
H

A mixture of 6 mg of nitrone 22 (0.0163 mmol), 6.9 mg of potassium superoxide
(0.097 mmol, 6 equiv.) and 8.6 mg of crown ether (0.032 mmol, 2equiv.) was dissolved 1
ml of benzene. The reaction was stirred for 3 hr at room temperature. The product was
washed with 10 ml of saturated sodium chloride several times, dried over magnesium
sulfate and concentrated. The mixture was purified by column chromatography using 5:5
hexane:ethylacetate to give 2.2 mg of crude 67 (43 %). It was not possible to obtain 67
pure enough for definitive NMR characterization. Nevertheless, the presence of
aldehyde-proton and up-field shifting of ethyl-proton in 1H NMR data suggested the
compound 67. When the same reaction was stirred for three days, another orange product
was observed. The 1H NMR was observed with no aldehyde-proton signal and LRMS
detected MH+ of 663. It was not possible to isolate the product 67 in a pure form for
structure identification.
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[5.2.8] Amide products 74 and 79 of superoxide trapping with nitrone 24

NH
O
N

O

Si

O

O

NC

O
O

N

NH

H

N

H

74

79

A mixture of 20 mg of nitrone 24, 7.5 mg of potassium superoxide and 18.6 mg of
crown ether was dissolved in 1 ml of benzene. The reaction was stirred for 16 hr at room
temperature. The mixture was then washed with 10 ml of saturated sodium chloride
several times, dried and concentrated. Purification of the mixture product by column
chromatography using 5:5 ethylacetate:hexane afforded 7.2 mg of orange amide 74 in 44
% yield. 1H NMR δ 8.8 (s, 1H), 7.7 (d, 1H J = 10.3), 7.63 (m, 2H), 7.56 (m, 1H), 7.40 (t,
1H J = 7.3), 7.7.33-7.22 (m, 4H), 7.0 (m, 1H), 6.24 (s, 1H), 1.57 (s, 9H), 1.48 (s, 9H); 13C
NMR δ 190.81, 172.62, 168.62, 157.58, 138.93, 138.43, 135.46, 133.20, 131.36, 128.35,
127.83, 127.12, 125.92, 125.11, 124.81, 122.05, 116.53, 115.0, 83.68, 63.42, 52.90,
29.90, 28.99; LRMS (LC/MS-ESI, MeOH) m/e 470 (MH+); HRMS calculated for
C29H31O3N3 found 470.2438. In addition to compound 74, trace of amide 79 was also
recovered which was not enough for NMR characterization. However, it was possible to
obtain consistent MS data: LRMS (LC/MS-ESI, MeOH) m/e 584 (MH+).
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[5.2.9] Amide products 80 and 81 of superoxide trapping by nitrone 25
NH
NH

O

N
N
H

O

NH2

O

N

NH

H

80
N

H
N

NH2
NH

Si
O

NC

O

N

N

O

H

81
A mixture of 15 mg of nitrone 25 (0.021 mmol), 4.4 mg (3 equiv.) of potassium
superoxide and 11.1 mg (2 equiv.) of crown ether was dissolved in 1 ml of benzene and
stirred for 19 hr. Work up was done as aforementioned method. The mixture product was
separated by column chromatography beginning with 98:2 dichloromethane:methanol
and increasing the polarity to 94:6 dichloromethane:methanol to provide crude brownish
orange product. LRMS analysis indicated the compound 80 with 654 (MH+) as a major
product and the compound 81 with 768 (MH+) as a minor product along with some
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starting material. It was not possible to separate the mixture pure enough for NMR
characterization.
[5.3.0] UV-vis and fluorescence analysis
UV-vis and fluorescence experiments were performed with assistance of Dr.
Moon’s students. The orange product 74 from the reaction of 2-tert-butyldimethylsilyl-3tert-butylnitrone-1-(2-tert-butyl-4-cyano-5-phenyl)-azulenylisoxazoline

(24)

with

superoxide was tested. Compound 74 was dissolved in ethanol for UV-vis absorbance
measurement in scan range of 200-400 nm with scan rate of 600 nm/min at average time
0.1 s and data interval of 1.00 nm. Fluorescence signal was obtained in scan range of
400-700 nm using 0.1 s integration time with an increment of 0.1 nm. Both the excitation
slit wide and the emission slit wide were selected 1.5 nm with the excitation wavelength
fixed at 390 nm.
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